drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Entacapone	Apomorphine	0.25	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	0.00978412123828898
Haloperidol	Biperiden	0.518	-2.373	Moderate	459 (144/315)		#ACCCE3	40.6050596204356	0
Mesalazine	Azathioprine	0.386	-1.196	Moderate	572 (272/300)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B4D1E6	50.6015122067302	0
Omeprazole	Diazepam	0.443	1.296	Moderate	20326 (11877/8449)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F8BABA	1798.12296698251	1
Carbamazepine	Levetiracetam	0.474	-1.026	Moderate	323 (166/157)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	28.5739308440102	0
Amiodarone	Acenocoumarol	0.431	-2.425	None	110 (34/76)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#ACCCE3	9.7310600397558	1.00414197576773e-204
Indomethacin	Methotrexate	0.329	1.414	Major	413 (250/163)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F8BABA	36.5357072401741	0
Digoxin	Carvedilol	0.364	-2.332	Moderate	63 (20/43)	Digoxin may increase the bradycardic activities of Carvedilol.	#ACCCE3	5.57324347731469	1.23005881614844e-125
Trimethoprim	Leucovorin	0.573	-2.425	Major	453 (140/313)		#ACCCE3	40.074274527358	0
Digoxin	Furosemide	0.401	-1.43	Moderate	102 (44/58)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#B2D0E5	9.02334658231902	6.91118625416259e-176
Methotrexate	Hydroxychloroquine	0.289	5.258	Minor	181 (154/27)		#EDA1A1	16.0120169745073	1.79983540837881e-198
Digoxin	Spironolactone	0.464	-1.43	Minor	51 (22/29)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#B2D0E5	4.51167329115951	4.56467503426449e-96
Digoxin	Amiodarone	0.423	-2.17	Major	27 (9/18)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#AECDE3	2.38853291884915	4.61794595274853e-56
Omeprazole	Alprazolam	0.295	1.545	Moderate	9661 (6050/3611)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F7B9B9	854.652464037098	1
Warfarin	Amiodarone	0.458	-1.446	Major	21 (9/12)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B2D0E5	1.85774782577156	2.93440292929007e-37
Lamotrigine	Carbamazepine	0.466	1.002	Moderate	215 (112/103)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#F9BCBC	19.0197991686136	3.38639656581543e-210
Pravastatin	Fenofibrate	0.845	-7.453	Major	244 (31/213)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#8CB4D5	21.585260451822	3.60635094085504e-312
Omeprazole	Clonazepam	0.321	-1.004	Moderate	3213 (1669/1544)		#B4D1E6	284.235417343049	1
Fluvoxamine	Clomipramine	0.37	-1.423	Major	141 (61/80)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#B2D0E5	12.4734496873233	2.83378406174718e-147
Mesalazine	Mercaptopurine	0.272	-1.179	Moderate	48 (23/25)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	4.24628074462071	4.73388985774162e-71
Valproic acid	Carbamazepine	0.516	-2.038	Moderate	308 (107/201)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#AECDE3	27.2469681113162	9.14226515449754e-250
Omeprazole	Methotrexate	0.303	1.821	Major	1190 (790/400)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F7B7B7	105.272376793722	8.28902604617772e-70
Ethinylestradiol	Amoxicillin	0.176	2025.346	Moderate	4396 (4394/2)		#B32020	388.888544861514	1
Trihexyphenidyl	Haloperidol	0.516	-3.495	Moderate	38 (9/29)		#A5C6DF	3.36163892282473	2.34623101012911e-65
Propranolol	Rizatriptan	0.37	2.803	Moderate	299 (225/74)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F4B1B1	26.4507904716999	7.08695407763959e-130
Haloperidol	Lithium cation	0.357	-1.266	Major	78 (36/42)	Lithium may increase the neurotoxic activities of Haloperidol.	#B2D0E5	6.90020621000866	9.3839933980825e-75
Phenytoin	Lamotrigine	0.486	-1.582	Moderate	59 (24/35)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#B1CFE5	5.21938674859629	2.67246495197131e-63
Carbamazepine	Risperidone	0.406	-1.857	Moderate	179 (66/113)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#AFCEE4	15.8350886101481	1.90490467677949e-115
Levothyroxine	Iron	0.212	85.35	Moderate	1123 (1111/12)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#B32020	99.3452765876888	0.00380641840806759
Amitriptyline	Duloxetine	0.347	3.914	Major	341 (276/65)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#F0A9A9	30.166286123243	1.07885501795601e-59
Fluoxetine	Clomipramine	0.356	1.173	Major	334 (187/147)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F9BCBC	29.5470368479858	1.08849796030328e-101
Dextropropoxyphene	Naltrexone	0.554	-1.808	None	8 (3/5)	The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.	#AFCEE4	0.707713457436786	3.57338494002022e-09
Fenofibrate	Atorvastatin	0.499	-5.776	Major	253 (40/213)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#97BCD9	22.3814380914383	1.43957799719573e-151
Digoxin	Verapamil	0.518	2.305	Moderate	7 (5/2)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#F5B4B4	0.619249275257188	4.55344689428676e-07
Cholestyramine	Ursodeoxycholic acid	0.328	1.383	None	35 (21/14)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F8BABA	3.09624637628594	3.83207886031417e-38
Tacrolimus	Atorvastatin	0.427	-2.021	Moderate	209 (73/136)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#AECDE3	18.489014075536	2.3616366124887e-96
Topiramate	Lithium cation	0.376	1.391	Moderate	143 (86/57)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F8BABA	12.6503780516825	4.323456704462e-66
Glimepiride	Repaglinide	0.307	4.609	None	6 (5/1)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#EEA4A4	0.530785093077589	3.44145347836332e-05
Ranolazine	Verapamil	0.143	Inf	Major	1 (1/0)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B32020	0.0884641821795982	1
Sulfasalazine	Azathioprine	0.392	1.536	Moderate	32 (20/12)		#F7B9B9	2.83085382974714	6.22224534048131e-28
Simvastatin	Fenofibrate	0.467	-5.405	Major	341 (57/284)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#99BDDA	30.166286123243	6.3118242656971e-130
Clozapine	Haloperidol	0.197	-2.324	Major	22 (7/15)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#ACCCE3	1.94621200795116	9.12498237511429e-27
Ramipril	Spironolactone	0.538	-1.656	Major	48 (19/29)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#B1CFE5	4.24628074462071	3.92183281398219e-40
Fluvoxamine	Olanzapine	0.421	-2.871	Moderate	124 (34/90)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#A9C9E1	10.9695585902702	1.15443716529e-82
Topiramate	Carbamazepine	0.396	-1.014	Moderate	149 (77/72)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B4D1E6	13.1811631447601	3.22809420552059e-52
Clozapine	Clonazepam	0.335	-2.118	Moderate	62 (21/41)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#AECDE3	5.48477929513509	1.75295903034633e-48
Acetaminophen	Acenocoumarol	0.246	-1.25	None	820 (381/439)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	72.5406293872705	1
Spironolactone	Enalapril	0.489	-1.749	Major	128 (49/79)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#AFCEE4	11.3234153189886	5.83549224389464e-60
Phenytoin	Vigabatrin	0.543	-1.085	Minor	4 (2/2)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B4D1E6	0.353856728718393	0.000219271094385903
Prednisone	Acetylsalicylic acid	0.386	2.044	Moderate	608 (419/189)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#F6B6B6	53.7862227651957	1
Methotrexate	Naproxen	0.27	1.87	Major	424 (284/140)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F7B7B7	37.5088132441496	1
Atorvastatin	Gemfibrozil	0.382	-3.556	Major	154 (36/118)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#A5C6DF	13.6234840556581	4.70925438476387e-33
Fluoxetine	Risperidone	0.353	-1.605	Moderate	310 (125/185)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#B1CFE5	27.4238964756754	2.81594165297576e-52
Amitriptyline	Fluoxetine	0.335	5.638	Major	370 (318/52)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#EB9E9E	32.7317474064513	1
Methotrexate	Phenylbutazone	0.148	1.291	Major	12 (7/5)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#F8BABA	1.06157018615518	1.72301754031723e-12
Diltiazem	Atorvastatin	0.467	-2.17	Moderate	48 (16/32)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#AECDE3	4.24628074462071	7.1331873862297e-36
Propranolol	Ibuprofen	0.271	2.156	Moderate	1125 (788/337)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F6B6B6	99.522204952048	1
Tramadol	Citalopram	0.258	2.423	Major	693 (502/191)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F5B4B4	61.3056782504616	1
Phenytoin	Oxcarbazepine	0.423	-1.627	Moderate	25 (10/15)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#B1CFE5	2.21160455448996	1.08331491130933e-17
Tramadol	Fluoxetine	0.235	4.18	Major	487 (399/88)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#F0A7A7	43.0820567214643	1
Omeprazole	Ketazolam	0.358	1.64	None	478 (306/172)		#F7B9B9	42.2858790818479	1
Diltiazem	Amiodarone	0.52	-2.531	Major	10 (3/7)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#ABCBE2	0.884641821795982	8.32515995660576e-13
Acetylsalicylic acid	Ibuprofen	0.283	1.09	Major	1698 (920/778)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#F9BCBC	150.212181340958	1
Pyridostigmine	Prednisone	0.405	2.049	Moderate	58 (40/18)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#F6B6B6	5.1309225664167	3.04099460843588e-23
Propranolol	Paroxetine	0.337	1.691	Moderate	326 (211/115)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F7B9B9	28.839323390549	0.0558233947789642
Tramadol	Paroxetine	0.227	2.287	Major	630 (449/181)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F5B4B4	55.7324347731469	1
Acetylsalicylic acid	Insulin aspart	0.313	-1.918	Moderate	263 (95/168)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#AFCEE4	23.2660799132343	2.25823937602776e-53
Spironolactone	Losartan	0.445	-1.356	Major	36 (16/20)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#B2D0E5	3.18471055846554	1.99628633707407e-22
Fenofibrate	Rosuvastatin	0.565	-7.352	Major	70 (9/61)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#8CB4D5	6.19249275257187	9.04092121870154e-55
Prednisone	Ethinylestradiol	0.167	559.574	Moderate	608 (607/1)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	53.7862227651957	1
Alprazolam	Clarithromycin	0.239	2.368	Moderate	885 (637/248)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F5B4B4	78.2908012289444	1
Carbamazepine	Aripiprazole	0.347	-1.16	Moderate	60 (29/31)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#B4D1E6	5.30785093077589	1.67004780747639e-22
Sumatriptan	Ergotamine	0.438	5.926	Major	52 (45/7)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#EB9C9C	4.60013747333911	2.54017317718915e-16
Propranolol	Escitalopram	0.308	1.608	None	225 (143/82)		#F7B9B9	19.9044409904096	2.22776624407555e-05
Cyclosporine	Sulfamethoxazole	0.322	-1.695	Major	41 (16/25)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	3.62703146936353	1.35966542971211e-26
Prazosin	Nadolol	0.167	Inf	Moderate	1 (1/0)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.0884641821795982	1
Atenolol	Ibuprofen	0.23	-1.118	Moderate	784 (386/398)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#B4D1E6	69.355918828805	1
Fluoxetine	Propranolol	0.326	2.377	Moderate	204 (147/57)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F5B4B4	18.046693164638	0.237720334908348
Sucralfate	Lansoprazole	0.616	-1.229	Moderate	64 (30/34)		#B4D1E6	5.66170765949429	5.04092523160685e-25
Azathioprine	Acenocoumarol	0.263	1.276	None	31 (18/13)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#F8BABA	2.74238964756754	5.00675741022597e-12
Fluoxetine	Lithium cation	0.356	1.229	Major	119 (68/51)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	10.5272376793722	3.24797768476507e-16
Cyclosporine	Tacrolimus	0.161	1.257	Major	26 (15/11)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#F8BABA	2.30006873666955	1.52649010493872e-11
Rifabutin	Warfarin	0.25	Inf	None	1 (1/0)	The metabolism of Warfarin can be increased when combined with Rifabutin.	#B32020	0.0884641821795982	1
Rosiglitazone	Gemfibrozil	0.654	Inf	Moderate	3 (3/0)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#B32020	0.265392546538795	1
Tramadol	Escitalopram	0.222	2.136	Major	398 (278/120)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F6B6B6	35.2087445074801	1
Atenolol	Chlorpropamide	1	Inf	Moderate	1 (1/0)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.0884641821795982	1
Haloperidol	Carbamazepine	0.367	-4.05	Moderate	71 (15/56)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#A2C4DE	6.28095693475147	6.78253599319917e-55
Ziprasidone	Carbamazepine	0.312	-1.085	Minor	22 (11/11)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#B4D1E6	1.94621200795116	2.54807327322323e-12
Bisoprolol	Ibuprofen	0.183	-1.208	Moderate	782 (370/412)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	69.1789904644458	1
Simvastatin	Gemfibrozil	0.308	-5.652	Major	236 (38/198)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#97BCD9	20.8775469943852	6.55689703765897e-22
Propranolol	Ergotamine	0.434	3.687	Moderate	55 (44/11)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F1ABAB	4.8655300198779	8.5923957617624e-12
Cyclosporine	Omeprazole	0.367	-1.253	Moderate	222 (103/119)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B2D0E5	19.6390484438708	1
Paroxetine	Risperidone	0.392	-2.416	Moderate	313 (97/216)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#ACCCE3	27.6892890222142	1.53812780709438e-15
Prednisone	Acenocoumarol	0.263	1.383	None	145 (87/58)		#F8BABA	12.8273064160417	1
Carbamazepine	Simvastatin	0.345	-1.842	Moderate	116 (43/73)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#AFCEE4	10.2618451328334	3.71050112854364e-10
Citalopram	Propranolol	0.326	1.844	Moderate	234 (156/78)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F7B7B7	20.700618630026	1
Propranolol	Sertraline	0.301	1.422	Moderate	178 (108/70)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F8BABA	15.7466244279685	0.00549807681492482
Acetylsalicylic acid	Acenocoumarol	0.366	-2.273	None	130 (42/88)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#ACCCE3	11.5003436833478	7.71994420115456e-35
Omeprazole	Itraconazole	0.324	1.251	Moderate	799 (460/339)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F8BABA	70.682881561499	1
Trospium	Oxybutynin	0.932	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#B32020	0.176928364359196	0.916389616583074
Ibuprofen	Lithium cation	0.134	1.109	Moderate	434 (237/197)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F9BCBC	38.3934550659456	1
Fluvoxamine	Carbamazepine	0.301	-1.162	Moderate	29 (14/15)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#B4D1E6	2.56546128320835	2.78487695132402e-12
Methotrexate	Amoxicillin	0.142	2.156	Major	434 (304/130)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F6B6B6	38.3934550659456	1
Acarbose	Digoxin	1	Inf	Moderate	1 (1/0)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#B32020	0.0884641821795982	1
Clozapine	Flunitrazepam	0.414	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Clozapine.	#B32020	0.176928364359196	1
Phenytoin	Topiramate	0.403	-1.88	Moderate	41 (15/26)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#AFCEE4	3.62703146936353	1.372690566715e-17
Fluoxetine	Rizatriptan	0.24	22.494	Major	127 (122/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#BA2F2F	11.234951136809	1
Phenytoin	Acenocoumarol	0.427	2.766	None	8 (6/2)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#F4B1B1	0.707713457436786	0.133682113745358
Fluconazole	Alprazolam	0.242	3.305	Major	486 (380/106)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F2AEAE	42.9935925392847	1
Prednisone	Estradiol	0.21	Inf	Moderate	253 (253/0)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	22.3814380914383	1
Venlafaxine	Metoclopramide	0.149	3.115	Moderate	254 (196/58)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F3AFAF	22.4699022736179	1
Torasemide	Tobramycin	0.143	Inf	Major	1 (1/0)	The serum concentration of Tobramycin can be increased when it is combined with Torasemide.	#B32020	0.0884641821795982	1
Spironolactone	Telmisartan	0.405	-1.302	Major	11 (5/6)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#B2D0E5	0.97310600397558	4.62135275829133e-07
Repaglinide	Gliclazide	0.38	-3.525	None	17 (4/13)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#A5C6DF	1.50389109705317	2.11276818210767e-15
Ergotamine	Rizatriptan	0.514	4.379	Major	46 (38/8)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#EFA6A6	4.06935238026152	3.2379104976635e-09
Propafenone	Acenocoumarol	0.387	-1.085	None	6 (3/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#B4D1E6	0.530785093077589	0.000587095078401204
Megestrol acetate	Primidone	0.519	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Omeprazole	Flurazepam	0.294	1.206	Moderate	150 (85/65)		#F9BCBC	13.2696273269397	1
Diazepam	Clarithromycin	0.372	2.077	Moderate	836 (579/257)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F6B6B6	73.9560563021441	1
Amitriptyline	Salbutamol	0.233	3.152	Moderate	380 (294/86)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F3AFAF	33.6163892282473	1
Dapsone	Trimethoprim	0.562	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Dapsone.	#B32020	0.176928364359196	1
Amitriptyline	Carbamazepine	0.426	1.449	Moderate	90 (55/35)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F8BABA	7.96177639616384	0.00121812926982861
Methotrexate	Ibuprofen	0.196	2.042	Major	389 (268/121)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F6B6B6	34.4125668678637	1
Citalopram	Clarithromycin	0.194	2.747	Major	394 (295/99)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F4B1B1	34.8548877787617	1
Citalopram	Rizatriptan	0.238	8.051	Major	146 (131/15)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#E48E8E	12.9157705982213	1
Clozapine	Lamotrigine	0.289	2.305	Moderate	7 (5/2)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#F5B4B4	0.619249275257188	0.044016739910871
Omeprazole	Midazolam	0.288	1.043	Moderate	179 (95/84)		#F9BCBC	15.8350886101481	1
Zolmitriptan	Escitalopram	0.257	5.152	Major	112 (95/17)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#EDA1A1	9.907988404115	1
Imipramine	Fluoxetine	0.288	1.356	Major	42 (25/17)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F8BABA	3.71549565154312	2.22591325819842e-12
Furosemide	Ibuprofen	0.299	1.699	Moderate	418 (271/147)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F7B9B9	36.9780281510721	1
Paroxetine	Rizatriptan	0.286	4.955	Major	153 (129/24)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#EDA3A3	13.5350198734785	1
Zolmitriptan	Fluoxetine	0.236	7.913	Major	115 (103/12)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#E59090	10.1733809506538	1
Acetylsalicylic acid	Glyburide	0.525	-2.953	Moderate	67 (18/49)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#A8C8E1	5.92710020603308	8.01187207612899e-29
Alprazolam	Carbamazepine	0.288	1.185	Moderate	176 (99/77)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F9BCBC	15.5696960636093	1
Methotrexate	Flurbiprofen	0.172	-1.356	Major	9 (4/5)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#B2D0E5	0.796177639616384	2.28483400561361e-07
Rizatriptan	Escitalopram	0.227	5.474	Major	111 (95/16)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#EC9F9F	9.8195242219354	1
Zolmitriptan	Paroxetine	0.185	8.033	Major	136 (122/14)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#E48E8E	12.0311287764254	1
Fluvoxamine	Lithium cation	0.427	-2.82	Major	36 (10/26)	Lithium may increase the serotonergic activities of Fluvoxamine.	#A9C9E1	3.18471055846554	1.75575512203804e-23
Fluconazole	Diazepam	0.335	2.831	Moderate	570 (430/140)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F4B1B1	50.424583842371	1
Fluvoxamine	Duloxetine	0.23	1.383	Major	35 (21/14)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F8BABA	3.09624637628594	3.03586217496481e-07
Spironolactone	Captopril	0.397	2.305	Major	7 (5/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#F5B4B4	0.619249275257188	0.00984844628736504
Diltiazem	Amlodipine	0.391	1.054	Moderate	15 (8/7)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#F9BCBC	1.32696273269397	8.43903178788923e-05
Amikacin	Furosemide	0.042	Inf	Major	1 (1/0)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#B32020	0.0884641821795982	1
Zolmitriptan	Ergotamine	0.478	5.9	Major	37 (32/5)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#EB9C9C	3.27317474064513	3.92161574551659e-05
Imipramine	Clonidine	0.162	Inf	Major	1 (1/0)	Imipramine may decrease the antihypertensive activities of Clonidine.	#B32020	0.0884641821795982	1
Pioglitazone	Gemfibrozil	0.325	-2.531	Major	10 (3/7)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#ABCBE2	0.884641821795982	5.04503201479333e-05
Citalopram	Zolmitriptan	0.199	4.456	Major	140 (116/24)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#EFA6A6	12.3849855051437	1
Fluoxetine	Clarithromycin	0.177	5.093	Moderate	261 (221/40)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#EDA1A1	23.0891515488751	1
Carbamazepine	Atorvastatin	0.307	-1.681	Moderate	51 (20/31)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B1CFE5	4.51167329115951	0.000241302244499986
Cyclosporine	Methotrexate	0.234	-1.205	Moderate	19 (9/10)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#B4D1E6	1.68081946141237	2.6142782768617e-08
Phenytoin	Omeprazole	0.311	-2.069	Moderate	157 (54/103)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#AECDE3	13.8888766021969	1
Acetylsalicylic acid	Insulin detemir	0.321	-1.86	Moderate	57 (21/36)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#AFCEE4	5.0424583842371	2.5547071943829e-16
Omeprazole	Halazepam	0.298	2.039	Moderate	106 (73/33)		#F6B6B6	9.37720331103741	1
Acetylsalicylic acid	Methylprednisolone	0.52	3.687	Moderate	80 (64/16)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#F1ABAB	7.07713457436786	1
Diltiazem	Simvastatin	0.504	-1.446	Major	28 (12/16)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B2D0E5	2.47699710102875	2.99069651390898e-05
Trimethoprim	Rifampicin	0.608	-2.837	Moderate	47 (13/34)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#A9C9E1	4.15781656244112	3.29564618946825e-21
Ethinylestradiol	Itraconazole	0.226	Inf	Moderate	161 (161/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#B32020	14.2427333309153	1
Clozapine	Carbamazepine	0.242	1.844	Major	6 (4/2)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#F7B7B7	0.530785093077589	0.540080987487849
Acetaminophen	Warfarin	0.232	-1.167	Minor	137 (66/71)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	12.119592958605	1
Dextromethorphan	Paroxetine	0.22	2.632	Major	266 (197/69)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F5B2B2	23.5314724597731	1
Cyclosporine	Atorvastatin	0.376	-3.254	Major	36 (9/27)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#A6C7E0	3.18471055846554	3.95924142580857e-14
Sumatriptan	Paroxetine	0.293	3.897	Major	115 (93/22)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#F0A9A9	10.1733809506538	1
Tramadol	Carbamazepine	0.345	-1.012	Moderate	116 (60/56)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#B4D1E6	10.2618451328334	1
Repaglinide	Glyburide	0.432	-1.627	None	5 (2/3)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B1CFE5	0.442320910897991	0.0189262357208666
Torasemide	Ibuprofen	0.252	1.83	Moderate	206 (137/69)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F7B7B7	18.2236215289972	1
Carbamazepine	Sertraline	0.295	-1.142	Moderate	78 (38/40)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#B4D1E6	6.90020621000866	0.617966030441243
Doxycycline	Ethinylestradiol	0.277	Inf	Moderate	125 (125/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Doxycycline.	#B32020	11.0580227724498	1
Citalopram	Sumatriptan	0.241	4.353	Major	103 (85/18)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#EFA6A6	9.11181076449862	1
Imipramine	Carbamazepine	0.251	2.766	Moderate	8 (6/2)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#F4B1B1	0.707713457436786	0.122195575835683
Ibuprofen	Acenocoumarol	0.169	-1.236	None	306 (143/163)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	27.0700397469571	1
Sotalol	Glyburide	1	Inf	Moderate	1 (1/0)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B32020	0.0884641821795982	1
Atenolol	Gliclazide	0.345	-1.193	None	21 (10/11)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	1.85774782577156	0.0472327449339677
Haloperidol	Propranolol	0.299	-1.695	Moderate	41 (16/25)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#B1CFE5	3.62703146936353	4.47045390580503e-09
Cyclosporine	Allopurinol	0.308	-7.051	Moderate	30 (4/26)		#8EB5D5	2.65392546538795	3.81784776156692e-16
Paroxetine	Almotriptan	0.27	9.68	Major	69 (63/6)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#DF8383	6.10402857039228	1
Methotrexate	Acetylsalicylic acid	0.294	2.371	Major	50 (36/14)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#F5B4B4	4.42320910897991	1
Almotriptan	Escitalopram	0.273	4.333	Major	57 (47/10)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#F0A7A7	5.0424583842371	1
Valproic acid	Acetylsalicylic acid	0.281	-1.766	Moderate	113 (43/70)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#AFCEE4	9.9964525862946	1
Methylphenidate	Rasagiline	0.71	Inf	Moderate	1 (1/0)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#B32020	0.0884641821795982	1
Sertraline	Clarithromycin	0.2	2.557	Moderate	200 (147/53)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F5B2B2	17.6928364359196	1
Topiramate	Ethinylestradiol	0.238	108.781	Moderate	119 (118/1)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Topiramate.	#B32020	10.5272376793722	1
Trospium	Solifenacin	0.22	1.844	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#F7B7B7	0.265392546538795	0.181369804090014
Fluoxetine	Sumatriptan	0.326	7.836	Major	76 (68/8)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#E59090	6.72327784564946	1
Alprazolam	Itraconazole	0.229	2.122	Major	241 (168/73)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F6B6B6	21.3198679052832	1
Rifampicin	Leflunomide	0.135	3.687	Major	5 (4/1)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#F1ABAB	0.442320910897991	0.988937166004937
Ibuprofen	Nadolol	0.265	2.53	Moderate	161 (118/43)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F5B2B2	14.2427333309153	1
Tacrolimus	Nifedipine	0.398	-3.254	Moderate	60 (15/45)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#A6C7E0	5.30785093077589	1.87237080544873e-30
Warfarin	Azathioprine	0.318	1.844	Moderate	6 (4/2)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F7B7B7	0.530785093077589	0.361199503474321
Methotrexate	Diclofenac	0.239	1.237	Major	185 (106/79)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F9BCBC	16.3658737032257	1
Haloperidol	Rifabutin	0.5	Inf	None	1 (1/0)	The metabolism of Haloperidol can be increased when combined with Rifabutin.	#B32020	0.0884641821795982	1
Fluoxetine	Dextromethorphan	0.224	2.98	Major	182 (139/43)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F3AFAF	16.1004811566869	1
Acetaminophen	Isoniazid	0.284	-1.198	Moderate	242 (115/127)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B4D1E6	21.4083320874628	1
Citalopram	Acenocoumarol	0.322	1.089	None	72 (39/33)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F9BCBC	6.36942111693107	1
Fluoxetine	Carbamazepine	0.315	1.112	Moderate	75 (41/34)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F9BCBC	6.63481366346987	1
Phenytoin	Levodopa	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#B32020	0.0884641821795982	1
Carbamazepine	Oxybutynin	0.376	1.383	None	10 (6/4)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#F8BABA	0.884641821795982	0.00814901607017759
Cyclosporine	Ezetimibe	0.395	-1.446	Moderate	7 (3/4)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#B2D0E5	0.619249275257188	0.069939575207308
Cyclosporine	Carvedilol	0.432	-2.893	Moderate	11 (3/8)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#A9C9E1	0.97310600397558	1.27891050093559e-06
Carbamazepine	Midazolam	0.272	-1.705	Moderate	18 (7/11)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#B1CFE5	1.59235527923277	1.04707065543347e-06
Cyclosporine	Repaglinide	0.434	1.844	Major	3 (2/1)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#F7B7B7	0.265392546538795	1
Eletriptan	Ergotamine	0.274	4.148	Major	11 (9/2)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#F0A7A7	0.97310600397558	0.00578755469668616
Olanzapine	Galantamine	0.045	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Labetalol	Ibuprofen	0.222	56.849	Moderate	188 (185/3)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B32020	16.6312662497645	1
Warfarin	Phenobarbital	0.43	Inf	Major	2 (2/0)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B32020	0.176928364359196	1
Phenytoin	Furosemide	0.309	-1.085	Minor	10 (5/5)	Phenytoin may decrease the diuretic activities of Furosemide.	#B4D1E6	0.884641821795982	0.0883940157276942
Spironolactone	Cholestyramine	0.511	3.687	Moderate	5 (4/1)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#F1ABAB	0.442320910897991	1
Folic acid	Phenytoin	0.383	1.251	Moderate	33 (19/14)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#F8BABA	2.91931801192674	1
Fluvoxamine	Mirtazapine	0.214	1.291	Major	24 (14/10)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F8BABA	2.12314037231036	1
Rifabutin	Clarithromycin	0.633	-1.266	Moderate	13 (6/7)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#B2D0E5	1.15003436833478	0.000139106089591357
Phenytoin	Dexamethasone	0.404	-2.17	Moderate	15 (5/10)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#AECDE3	1.32696273269397	4.24383492212115e-05
Tizanidine	Ethinylestradiol	0.201	Inf	Major	85 (85/0)		#B32020	7.51945548526585	1
Hydrocortisone	Phenobarbital	0.251	-1.627	Moderate	25 (10/15)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B1CFE5	2.21160455448996	0.000417566790824763
Dihydroergotamine	Sumatriptan	0.545	1.729	Major	23 (15/8)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B7B7	2.03467619013076	0.000892316121267783
Ticlopidine	Acetylsalicylic acid	0.083	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#B32020	0.0884641821795982	1
Levothyroxine	Acenocoumarol	0.243	2.458	None	55 (40/15)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F5B2B2	4.8655300198779	1
Alendronic acid	Ibuprofen	0.213	1.928	Moderate	136 (92/44)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#F7B7B7	12.0311287764254	1
Diazepam	Itraconazole	0.347	1.771	Moderate	298 (196/102)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F7B7B7	26.3623262895203	1
Doxycycline	Amoxicillin	0.5	1.243	Moderate	533 (306/227)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#F8BABA	47.1514091017258	1
Bisoprolol	Glyburide	0.377	-1.627	Moderate	15 (6/9)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#B1CFE5	1.32696273269397	0.0151263631145729
Eletriptan	Sertraline	0.298	3.38	Major	28 (22/6)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#F2AEAE	2.47699710102875	1
Imipramine	Duloxetine	0.284	2.074	Major	13 (9/4)	Duloxetine may increase the serotonergic activities of Imipramine.	#F6B6B6	1.15003436833478	0.0370532500021715
Cyclosporine	Simvastatin	0.374	-1.381	Major	25 (11/14)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	2.21160455448996	1
Carvedilol	Insulin detemir	0.373	Inf	Moderate	3 (3/0)		#B32020	0.265392546538795	1
Citalopram	Eletriptan	0.255	7.144	Major	35 (31/4)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#E79494	3.09624637628594	1
Atomoxetine	Fluoxetine	0.303	1.844	Major	12 (8/4)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#F7B7B7	1.06157018615518	0.259425413889523
Eletriptan	Venlafaxine	0.23	5.531	Major	21 (18/3)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#EC9F9F	1.85774782577156	1
Cyclosporine	Pravastatin	0.552	-2.531	Major	10 (3/7)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#ABCBE2	0.884641821795982	0.000523499931905599
Erythromycin	Alprazolam	0.214	2.693	Moderate	149 (111/38)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F4B1B1	13.1811631447601	1
Lovastatin	Verapamil	1	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#B32020	0.0884641821795982	1
Acetylsalicylic acid	Dexamethasone	0.454	3.572	Moderate	39 (31/8)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#F2ACAC	3.45010310500433	1
Warfarin	Acetylsalicylic acid	0.429	-1.928	Major	25 (9/16)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#AFCEE4	2.21160455448996	3.22035326616466e-06
Fluoxetine	Ergotamine	0.24	4.741	Major	43 (36/7)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#EEA4A4	3.80395983372272	1
Phenytoin	Clozapine	0.595	-1.085	Moderate	2 (1/1)	The serum concentration of Clozapine can be decreased when it is combined with Phenytoin.	#B4D1E6	0.176928364359196	1
Acetylsalicylic acid	Gliclazide	0.505	-4	None	75 (16/59)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#A2C4DE	6.63481366346987	3.95883192929596e-14
Duloxetine	Nortriptyline	0.433	5.531	Major	7 (6/1)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#EC9F9F	0.619249275257188	1
Folic acid	Phenobarbital	0.322	1.767	Moderate	35 (23/12)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#F7B7B7	3.09624637628594	1
Cyclosporine	Nifedipine	0.307	1.536	Moderate	8 (5/3)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#F7B9B9	0.707713457436786	0.135907284195025
Bisoprolol	Gliclazide	0.379	-2.983	None	30 (8/22)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#A8C8E1	2.65392546538795	1.47179151977212e-05
Salbutamol	Clomipramine	0.14	-1.291	Moderate	138 (63/75)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#B2D0E5	12.2080571407846	1
Methimazole	Acenocoumarol	0.365	2.074	None	13 (9/4)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F6B6B6	1.15003436833478	1
Digoxin	Hydrochlorothiazide	0.327	1.152	Moderate	9 (5/4)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#F9BCBC	0.796177639616384	0.453659436778401
Theophylline	Phenobarbital	0.03	Inf	Moderate	2 (2/0)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#B32020	0.176928364359196	1
Phenytoin	Diazepam	0.245	-2.33	Moderate	85 (27/58)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#ACCCE3	7.51945548526585	1
Fluoxetine	Nortriptyline	0.288	1.536	Major	16 (10/6)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F7B9B9	1.41542691487357	0.0448542007665248
Nabumetone	Acenocoumarol	0.15	3.687	None	5 (4/1)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F1ABAB	0.442320910897991	1
Sumatriptan	Escitalopram	0.239	4.333	Major	57 (47/10)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F0A7A7	5.0424583842371	1
Ethinylestradiol	Etoricoxib	0.178	Inf	None	68 (68/0)	Etoricoxib may increase the thrombogenic activities of Ethinyl Estradiol.	#B32020	6.01556438821268	1
Fluconazole	Clonazepam	0.191	1.749	None	113 (74/39)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F7B7B7	9.9964525862946	1
Oxycodone	Escitalopram	0.201	2.107	Moderate	23 (16/7)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F6B6B6	2.03467619013076	1
Lovastatin	Diltiazem	1	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#B32020	0.0884641821795982	1
Atenolol	Glyburide	0.566	-1.302	Moderate	11 (5/6)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	0.97310600397558	0.813501300903727
Duloxetine	Ciprofloxacin	0.19	1.997	Major	114 (78/36)		#F6B6B6	10.0849167684742	1
Ethinylestradiol	Cloxacillin	0.205	Inf	Moderate	127 (127/0)		#B32020	11.234951136809	1
Naproxen	Lithium cation	0.133	1.681	Major	96 (62/34)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F7B9B9	8.49256148924143	1
Fluconazole	Amitriptyline	0.295	7.298	Moderate	107 (95/12)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#E69393	9.46566749321701	1
Propranolol	Salbutamol	0.239	1.844	Major	147 (98/49)		#F7B7B7	13.0042347804009	1
Lovastatin	Acenocoumarol	0.625	Inf	None	2 (2/0)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#B32020	0.176928364359196	1
Bisoprolol	Salbutamol	0.196	-1.485	Moderate	154 (65/89)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	13.6234840556581	1
Fenofibrate	Fluvastatin	0.555	-10.848	Major	22 (2/20)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#76A3CB	1.94621200795116	2.11614870188932e-14
Nortriptyline	Carbamazepine	0.129	Inf	Moderate	3 (3/0)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#B32020	0.265392546538795	1
Fluconazole	Rifabutin	0.283	1.229	Moderate	7 (4/3)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#F9BCBC	0.619249275257188	0.158604259602479
Piroxicam	Methotrexate	0.212	3.687	Major	5 (4/1)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#F1ABAB	0.442320910897991	1
Fluoxetine	Almotriptan	0.233	6.822	Major	42 (37/5)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#E89696	3.71549565154312	1
Venlafaxine	Almotriptan	0.266	4.794	Major	31 (26/5)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#EEA4A4	2.74238964756754	1
Citalopram	Almotriptan	0.249	4.507	Major	53 (44/9)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#EFA6A6	4.68860165551871	1
Phenoxymethylpenicillin	Ethinylestradiol	0.186	Inf	Moderate	90 (90/0)		#B32020	7.96177639616384	1
Metoprolol	Gliclazide	0.573	Inf	None	2 (2/0)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#B32020	0.176928364359196	1
Dihydroergotamine	Rizatriptan	0.357	3.227	Major	18 (14/4)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#F2AEAE	1.59235527923277	1
Phenytoin	Hydrocortisone	0.287	-2.35	Moderate	19 (6/13)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#ACCCE3	1.68081946141237	0.00777243871905529
Dihydroergotamine	Propranolol	0.387	6.453	Moderate	16 (14/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#E99999	1.41542691487357	1
Diclofenac	Lithium cation	0.075	-1.351	Moderate	137 (61/76)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#B2D0E5	12.119592958605	1
Acetylsalicylic acid	Insulin glulisine	0.247	-2.17	Moderate	33 (11/22)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#AECDE3	2.91931801192674	0.00439239564609697
Verapamil	Atorvastatin	0.391	-2.17	Moderate	12 (4/8)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AECDE3	1.06157018615518	1
Venlafaxine	Naratriptan	0.362	5.531	Major	7 (6/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#EC9F9F	0.619249275257188	1
Eletriptan	Paroxetine	0.24	3.424	Major	33 (26/7)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#F2ACAC	2.91931801192674	1
Fluconazole	Simvastatin	0.229	1.024	Major	114 (60/54)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	10.0849167684742	1
Ranitidine	Acenocoumarol	0.347	1.213	None	44 (25/19)		#F9BCBC	3.89242401590232	1
Clozapine	Diazepam	0.311	-2.042	Major	49 (17/32)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#AECDE3	4.33474492680031	1
Salbutamol	Carvedilol	0.236	-1.04	Major	47 (24/23)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#B4D1E6	4.15781656244112	1
Bisoprolol	Verapamil	0.177	-1.356	Major	9 (4/5)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B2D0E5	0.796177639616384	1
Simvastatin	Clarithromycin	0.193	-1.959	Major	202 (72/130)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#AECDE3	17.8697648002788	1
Indomethacin	Alendronic acid	0.304	1.054	Moderate	15 (8/7)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#F9BCBC	1.32696273269397	1
Trospium	Risperidone	0.385	-1.085	Moderate	4 (2/2)		#B4D1E6	0.353856728718393	1
Cyclosporine	Tenoxicam	0.25	Inf	None	1 (1/0)	Tenoxicam may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0884641821795982	1
Methylphenidate	Carbamazepine	0.227	3.227	None	9 (7/2)		#F2AEAE	0.796177639616384	1
Bisoprolol	Insulin aspart	0.235	-2.531	Moderate	50 (15/35)		#ABCBE2	4.42320910897991	0.818101939649797
Methylprednisolone	Clarithromycin	0.725	1.406	Major	101 (61/40)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F8BABA	8.93488240013942	1
Trospium	Tolterodine	0.268	-1.085	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#B4D1E6	0.176928364359196	1
Estradiol	Phenobarbital	0.201	Inf	Moderate	11 (11/0)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#B32020	0.97310600397558	1
Colestipol	Ursodeoxycholic acid	0.263	-1.085	None	2 (1/1)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#B4D1E6	0.176928364359196	1
Pravastatin	Gemfibrozil	0.386	-5.153	Major	23 (4/19)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#9ABEDB	2.03467619013076	0.102737387737279
Erythromycin	Diazepam	0.307	2.388	Moderate	158 (114/44)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F5B4B4	13.9773407843765	1
Clozapine	Fluoxetine	0.335	-2.015	Moderate	20 (7/13)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#AECDE3	1.76928364359196	0.012239005996104
Fluoxetine	Moclobemide	0.611	Inf	None	3 (3/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.	#B32020	0.265392546538795	1
Phenytoin	Quetiapine	0.281	-3.254	Major	20 (5/15)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#A6C7E0	1.76928364359196	0.00187435500119168
Digoxin	Telmisartan	1	Inf	Moderate	1 (1/0)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#B32020	0.0884641821795982	1
Fluoxetine	Oxycodone	0.255	6.914	Moderate	17 (15/2)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#E89696	1.50389109705317	1
Phenytoin	Alprazolam	0.318	-1.212	Moderate	36 (17/19)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#B4D1E6	3.18471055846554	1
Ranolazine	Simvastatin	0.057	-1.085	Major	2 (1/1)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#B4D1E6	0.176928364359196	1
Allopurinol	Acenocoumarol	0.408	-7.322	None	31 (4/27)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#8CB4D5	2.74238964756754	4.14200224712998e-06
Zolmitriptan	Dihydroergotamine	0.401	1.844	Major	18 (12/6)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F7B7B7	1.59235527923277	1
Ciprofloxacin	Acenocoumarol	0.198	-1.384	None	66 (29/37)		#B2D0E5	5.83863602385348	1
Dihydroergotamine	Almotriptan	0.361	7.375	Major	9 (8/1)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#E69393	0.796177639616384	1
Sulfasalazine	Mercaptopurine	0.379	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Chlorthalidone	Digoxin	0.383	-1.085	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#B4D1E6	0.176928364359196	1
Carbamazepine	Verapamil	0.237	-1.085	Major	6 (3/3)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#B4D1E6	0.530785093077589	1
Ergotamine	Nadolol	0.37	1.383	Moderate	10 (6/4)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F8BABA	0.884641821795982	0.0745540228824182
Spironolactone	Eplerenone	0.225	-7.593	Major	8 (1/7)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#8BB3D4	0.707713457436786	3.97295538562703e-07
Phenytoin	Megestrol acetate	1	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Mirtazapine	Clonidine	0.448	-1.085	Moderate	4 (2/2)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#B4D1E6	0.353856728718393	1
Metoprolol	Verapamil	0.091	Inf	Major	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#B32020	0.0884641821795982	1
Paroxetine	Propafenone	0.169	5.531	Moderate	7 (6/1)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#EC9F9F	0.619249275257188	1
Cyclosporine	Sevelamer	0.181	-1.085	Moderate	2 (1/1)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#B4D1E6	0.176928364359196	1
Simvastatin	Amiodarone	0.339	-2.441	Major	13 (4/9)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#ABCBE2	1.15003436833478	1
Oxycodone	Sertraline	0.266	1.383	Moderate	20 (12/8)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F8BABA	1.76928364359196	1
Moclobemide	Clomipramine	0.568	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.0884641821795982	1
Ergotamine	Almotriptan	0.43	3.073	Major	13 (10/3)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#F3AFAF	1.15003436833478	1
Cyclosporine	Ursodeoxycholic acid	0.532	-2.17	Minor	9 (3/6)		#AECDE3	0.796177639616384	0.00118303269311149
Erythromycin	Citalopram	0.184	2.151	Major	80 (56/24)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F6B6B6	7.07713457436786	1
Cyclosporine	Ibuprofen	0.159	-1.21	Moderate	110 (52/58)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	9.7310600397558	1
Methotrexate	Cholestyramine	0.132	1.152	None	9 (5/4)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	0.796177639616384	1
Prednisone	Warfarin	0.256	-1.085	Moderate	26 (13/13)	Prednisone may increase the anticoagulant activities of Warfarin.	#B4D1E6	2.30006873666955	1
Phenytoin	Fludrocortisone	0.179	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#B32020	0.0884641821795982	1
Azithromycin	Acenocoumarol	0.102	1.251	None	66 (38/28)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#F8BABA	5.83863602385348	1
Almotriptan	Sertraline	0.206	7.682	Major	28 (25/3)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#E69191	2.47699710102875	1
Indomethacin	Propranolol	0.37	2.766	Moderate	28 (21/7)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F4B1B1	2.47699710102875	1
Fluoxetine	Acenocoumarol	0.251	1.024	None	38 (20/18)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F9BCBC	3.36163892282473	1
Sertraline	Rasagiline	0.53	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B32020	0.176928364359196	1
Eletriptan	Escitalopram	0.258	14.75	Major	17 (16/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#D06262	1.50389109705317	1
Raloxifene	Estradiol	0.308	Inf	Moderate	4 (4/0)		#B32020	0.353856728718393	1
Clonazepam	Itraconazole	0.19	1.892	None	58 (39/19)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F7B7B7	5.1309225664167	1
Estradiol	Primidone	0.202	Inf	Moderate	3 (3/0)	The metabolism of Estradiol can be increased when combined with Primidone.	#B32020	0.265392546538795	1
Levothyroxine	Warfarin	0.281	3.38	Moderate	14 (11/3)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F2AEAE	1.23849855051438	1
Lamotrigine	Ethinylestradiol	0.18	Inf	Moderate	36 (36/0)	The serum concentration of Lamotrigine can be decreased when it is combined with Ethinyl Estradiol.	#B32020	3.18471055846554	1
Erythromycin	Fluoxetine	0.199	4.056	Moderate	54 (44/10)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#F0A9A9	4.7770658376983	1
Itraconazole	Budesonide	0.421	-1.094	Major	229 (114/115)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B4D1E6	20.258297719128	1
Levothyroxine	Cholestyramine	0.24	3.319	Moderate	23 (18/5)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F2AEAE	2.03467619013076	1
Paroxetine	Carvedilol	0.278	1.076	Moderate	26 (14/12)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F9BCBC	2.30006873666955	1
Ezetimibe	Cholestyramine	0.155	-6.509	Moderate	14 (2/12)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#91B7D7	1.23849855051438	3.75042993817749e-09
Trospium	Tiotropium	0.314	Inf	Moderate	1 (1/0)	Trospium may increase the anticholinergic activities of Tiotropium.	#B32020	0.0884641821795982	1
Rosuvastatin	Gemfibrozil	0.329	-3.616	Major	13 (3/10)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#A5C6DF	1.15003436833478	1
Methylprednisolone	Phenobarbital	0.133	-1.808	Moderate	16 (6/10)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#AFCEE4	1.41542691487357	0.445514510972623
Lorazepam	Phenytoin	0.251	-2.17	Moderate	39 (13/26)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#AECDE3	3.45010310500433	1
Ibuprofen	Carvedilol	0.152	-2.193	Moderate	139 (46/93)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#AECDE3	12.2965213229642	1
Lorazepam	Clozapine	0.279	-1.808	Major	24 (9/15)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#AFCEE4	2.12314037231036	1
Omeprazole	Cilostazol	0.273	1.037	Major	17 (9/8)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#F9BCBC	1.50389109705317	1
Cimetidine	Nifedipine	0.05	Inf	Moderate	1 (1/0)	The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.	#B32020	0.0884641821795982	1
Gemfibrozil	Acenocoumarol	0.305	-3.254	None	20 (5/15)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#A6C7E0	1.76928364359196	1
Fluoxetine	Trimipramine	0.733	-2.17	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#AECDE3	0.265392546538795	1
Fluconazole	Atorvastatin	0.142	-1.122	Major	59 (29/30)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B4D1E6	5.21938674859629	1
Frovatriptan	Escitalopram	0.179	Inf	Major	11 (11/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#B32020	0.97310600397558	1
Atomoxetine	Haloperidol	0.839	Inf	Major	1 (1/0)	The metabolism of Haloperidol can be decreased when combined with Atomoxetine.	#B32020	0.0884641821795982	1
Valproic acid	Nimodipine	0.243	-2.17	Minor	9 (3/6)		#AECDE3	0.796177639616384	0.0685754009144533
Cyclosporine	Digoxin	0.2	Inf	Moderate	1 (1/0)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#B32020	0.0884641821795982	1
Repaglinide	Gemfibrozil	0.223	-5.424	Major	12 (2/10)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#99BDDA	1.06157018615518	0.0405149057286316
Escitalopram	Rasagiline	0.397	1.844	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#F7B7B7	0.265392546538795	1
Fluvoxamine	Imipramine	0.248	-1.085	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#B4D1E6	0.353856728718393	1
Propranolol	Primidone	0.366	-1.085	Moderate	4 (2/2)	The metabolism of Propranolol can be increased when combined with Primidone.	#B4D1E6	0.353856728718393	1
Fluoxetine	Frovatriptan	0.201	11.062	Major	13 (12/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#DB7A7A	1.15003436833478	1
Prednisone	Itraconazole	0.53	1.517	Moderate	127 (79/48)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F7B9B9	11.234951136809	1
Alendronic acid	Naproxen	0.285	1.681	Moderate	48 (31/17)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#F7B9B9	4.24628074462071	1
Warfarin	Ibuprofen	0.148	1.021	Major	59 (31/28)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#F9BCBC	5.21938674859629	1
Levofloxacin	Acenocoumarol	0.075	-1.559	None	39 (16/23)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	3.45010310500433	1
Eletriptan	Fluoxetine	0.302	Inf	Major	16 (16/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	1.41542691487357	1
Chlorpromazine	Propranolol	0.291	-1.356	Moderate	9 (4/5)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#B2D0E5	0.796177639616384	1
Ciprofloxacin	Iron	0.507	6.914	Moderate	153 (135/18)		#E89696	13.5350198734785	1
Cyclosporine	Ciprofloxacin	0.22	-1.012	Moderate	29 (15/14)		#B4D1E6	2.56546128320835	1
Fluvoxamine	Amitriptyline	0.311	2.996	Major	17 (13/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F3AFAF	1.50389109705317	1
Betamethasone	Acetylsalicylic acid	0.294	6.453	Moderate	16 (14/2)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#E99999	1.41542691487357	1
Ciprofloxacin	Methotrexate	0.12	1.383	Moderate	55 (33/22)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F8BABA	4.8655300198779	1
Ziprasidone	Chlorpromazine	0.708	-1.085	Major	2 (1/1)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B4D1E6	0.176928364359196	1
Citalopram	Warfarin	0.208	1.185	Moderate	16 (9/7)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F9BCBC	1.41542691487357	1
Ergotamine	Naratriptan	0.512	Inf	Major	2 (2/0)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.176928364359196	1
Omeprazole	Ketoconazole	0.443	-1.085	Moderate	84 (42/42)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B4D1E6	7.43099130308625	1
Fluconazole	Fentanyl	0.42	1.959	Major	25 (17/8)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#F6B6B6	2.21160455448996	1
Ciprofloxacin	Warfarin	0.19	1.317	Major	17 (10/7)		#F8BABA	1.50389109705317	1
Paroxetine	Acenocoumarol	0.3	1.139	None	38 (21/17)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	3.36163892282473	1
Venlafaxine	Frovatriptan	0.247	7.375	Major	9 (8/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#E69393	0.796177639616384	1
Digoxin	Levothyroxine	0.17	3.687	Moderate	10 (8/2)		#F1ABAB	0.884641821795982	1
Salbutamol	Oxprenolol	0.269	Inf	None	2 (2/0)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#B32020	0.176928364359196	1
Rifabutin	Tacrolimus	0.154	Inf	None	1 (1/0)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifabutin.	#B32020	0.0884641821795982	1
Spironolactone	Perindopril	0.483	-1.085	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#B4D1E6	0.176928364359196	1
Propranolol	Phenobarbital	0.396	-1.808	Moderate	16 (6/10)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#AFCEE4	1.41542691487357	1
Erythromycin	Sertraline	0.13	2.95	Moderate	42 (32/10)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F3AFAF	3.71549565154312	1
Digoxin	Methimazole	0.113	1.844	Moderate	3 (2/1)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#F7B7B7	0.265392546538795	1
Enalapril	Drospirenone	0.201	Inf	Moderate	31 (31/0)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#B32020	2.74238964756754	1
Cyclosporine	Fluvastatin	0.224	-1.085	Moderate	2 (1/1)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#B4D1E6	0.176928364359196	1
Lamotrigine	Norethisterone	0.209	Inf	Moderate	9 (9/0)		#B32020	0.796177639616384	1
Digoxin	Minocycline	0.145	Inf	Moderate	2 (2/0)		#B32020	0.176928364359196	1
Ziprasidone	Ketoconazole	0.112	Inf	Major	2 (2/0)	The metabolism of Ziprasidone can be decreased when combined with Ketoconazole.	#B32020	0.176928364359196	1
Bisoprolol	Formoterol	0.233	-1.519	Moderate	60 (25/35)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B1CFE5	5.30785093077589	1
Paroxetine	Frovatriptan	0.203	5.992	None	15 (13/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#EB9C9C	1.32696273269397	1
Pimozide	Escitalopram	0.321	-2.983	Major	15 (4/11)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#A8C8E1	1.32696273269397	0.00631744528420746
Atenolol	Diltiazem	0.301	-1.808	Major	8 (3/5)	Diltiazem may increase the hypotensive activities of Atenolol.	#AFCEE4	0.707713457436786	1
Cyclosporine	Azithromycin	0.165	1.251	Moderate	33 (19/14)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#F8BABA	2.91931801192674	1
Dihydroergotamine	Fluoxetine	0.3	2.95	Major	21 (16/5)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F3AFAF	1.85774782577156	1
Tetracycline	Ethinylestradiol	0.346	Inf	None	21 (21/0)		#B32020	1.85774782577156	1
Atenolol	Clonidine	0.545	Inf	Major	1 (1/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B32020	0.0884641821795982	1
Phenytoin	Trimethoprim	0.168	2.766	Moderate	4 (3/1)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#F4B1B1	0.353856728718393	1
Diclofenac	Alendronic acid	0.277	1.986	Moderate	41 (28/13)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#F6B6B6	3.62703146936353	1
Conjugated estrogens	Phenobarbital	0.455	Inf	Moderate	1 (1/0)	The metabolism of Conjugated estrogens can be increased when combined with Phenobarbital.	#B32020	0.0884641821795982	1
Enalapril	Tizanidine	0.202	-1.233	Major	47 (22/25)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#B4D1E6	4.15781656244112	1
Citalopram	Oxycodone	0.349	1.712	Moderate	20 (13/7)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F7B9B9	1.76928364359196	1
Mirtazapine	Donepezil	0.312	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Warfarin	Ranitidine	0.343	3.227	Moderate	9 (7/2)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#F2AEAE	0.796177639616384	1
Megestrol acetate	Phenobarbital	0.286	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Galantamine	Sertraline	0.167	Inf	Moderate	1 (1/0)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#B32020	0.0884641821795982	1
Oxycodone	Paroxetine	0.256	2.397	Moderate	18 (13/5)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F5B4B4	1.59235527923277	1
Cyclosporine	Roxithromycin	0.222	Inf	None	1 (1/0)	The metabolism of Roxithromycin can be decreased when combined with Cyclosporine.	#B32020	0.0884641821795982	1
Hydrochlorothiazide	Lithium cation	0.279	-1.446	Major	21 (9/12)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B2D0E5	1.85774782577156	1
Erythromycin	Levofloxacin	0.745	-1.015	Moderate	60 (31/29)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#B4D1E6	5.30785093077589	1
Phenytoin	Fluoxetine	0.507	-1.24	Moderate	15 (7/8)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#B2D0E5	1.32696273269397	1
Fluvoxamine	Clozapine	0.363	-4.339	Moderate	5 (1/4)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#A0C3DD	0.442320910897991	0.0787931193630367
Carvedilol	Insulin aspart	0.338	-2.712	Moderate	14 (4/10)		#A9C9E1	1.23849855051438	1
Metronidazole	Lithium cation	0.083	3.227	Moderate	18 (14/4)		#F2AEAE	1.59235527923277	1
Prednisone	Rifampicin	0.374	-1.386	Moderate	41 (18/23)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#B2D0E5	3.62703146936353	1
Clonidine	Bisoprolol	0.417	-1.085	Major	2 (1/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	0.176928364359196	1
Bisoprolol	Insulin detemir	0.406	1.229	Moderate	7 (4/3)		#F9BCBC	0.619249275257188	1
Sertraline	Propafenone	0.192	Inf	Moderate	3 (3/0)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#B32020	0.265392546538795	1
Lovastatin	Fenofibrate	0.059	Inf	Major	1 (1/0)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#B32020	0.0884641821795982	1
Atenolol	Salbutamol	0.22	-1.256	Moderate	82 (38/44)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	7.25406293872705	1
Erythromycin	Moxifloxacin	0.787	2.502	Major	26 (19/7)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F5B2B2	2.30006873666955	1
Clozapine	Sertraline	0.314	-3.525	Major	17 (4/13)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#A5C6DF	1.50389109705317	0.0245828774889419
Simvastatin	Itraconazole	0.2	-2.044	Major	75 (26/49)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#AECDE3	6.63481366346987	1
Digoxin	Alprazolam	0.339	4.148	Moderate	11 (9/2)		#F0A7A7	0.97310600397558	1
Fluconazole	Tacrolimus	0.428	2.212	Major	34 (24/10)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#F5B4B4	3.00778219410634	1
Fluoxetine	Carvedilol	0.43	-1.687	Moderate	23 (9/14)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#B1CFE5	2.03467619013076	1
Fluvoxamine	Frovatriptan	0.425	Inf	Major	2 (2/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.176928364359196	1
Enalapril	Lithium cation	0.179	-1.676	Moderate	28 (11/17)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#B1CFE5	2.47699710102875	1
Oxcarbazepine	Ethinylestradiol	0.179	Inf	Major	22 (22/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Oxcarbazepine.	#B32020	1.94621200795116	1
Ciprofloxacin	Sevelamer	0.236	-1.808	Moderate	16 (6/10)		#AFCEE4	1.41542691487357	1
Gentamicin	Cefuroxime	0.624	1.229	Moderate	7 (4/3)		#F9BCBC	0.619249275257188	1
Atenolol	Ergotamine	0.258	6.453	Moderate	8 (7/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#E99999	0.707713457436786	1
Carvedilol	Escitalopram	0.29	-2.712	None	28 (8/20)		#A9C9E1	2.47699710102875	1
Labetalol	Salbutamol	0.174	33.187	Major	37 (36/1)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#B32020	3.27317474064513	1
Moxifloxacin	Acenocoumarol	0.164	-1.085	None	16 (8/8)		#B4D1E6	1.41542691487357	1
Minocycline	Amoxicillin	0.458	1.303	Moderate	140 (82/58)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F8BABA	12.3849855051437	1
Propranolol	Formoterol	0.224	1.69	Major	51 (33/18)		#F7B9B9	4.51167329115951	1
Pantoprazole	Itraconazole	0.361	1.598	Moderate	41 (26/15)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F7B9B9	3.62703146936353	1
Fluconazole	Carbamazepine	0.124	2.189	Moderate	27 (19/8)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F6B6B6	2.38853291884915	1
Telmisartan	Lithium cation	0.181	-1.085	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B4D1E6	0.353856728718393	1
Theophylline	Clarithromycin	0.809	1.659	Moderate	14 (9/5)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#F7B9B9	1.23849855051438	1
Ergotamine	Frovatriptan	0.397	Inf	Major	3 (3/0)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.265392546538795	1
Metoprolol	Sertraline	0.158	Inf	Moderate	5 (5/0)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#B32020	0.442320910897991	1
Fluvoxamine	Naratriptan	0.5	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Naratriptan.	#B32020	0.0884641821795982	1
Phenytoin	Estradiol	0.202	2.305	Moderate	7 (5/2)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#F5B4B4	0.619249275257188	1
Fentanyl	Amiodarone	0.361	-1.085	Major	2 (1/1)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#B4D1E6	0.176928364359196	1
Spironolactone	Lisinopril	0.269	-1.085	Major	6 (3/3)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B4D1E6	0.530785093077589	1
Fluconazole	Midazolam	0.207	Inf	Major	10 (10/0)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#B32020	0.884641821795982	1
Ethinylestradiol	Minocycline	0.225	Inf	Moderate	26 (26/0)		#B32020	2.30006873666955	1
Carbamazepine	Doxepin	0.071	Inf	Moderate	1 (1/0)	The metabolism of Doxepin can be increased when combined with Carbamazepine.	#B32020	0.0884641821795982	1
Amitriptyline	Clonidine	0.088	Inf	Major	2 (2/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.176928364359196	1
Pimozide	Sertraline	0.249	-1.446	Major	7 (3/4)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#B2D0E5	0.619249275257188	1
Erythromycin	Simvastatin	0.133	-1.205	Major	38 (18/20)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#B4D1E6	3.36163892282473	1
Citalopram	Clozapine	0.41	-2.386	Major	16 (5/11)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#ACCCE3	1.41542691487357	1
Phenytoin	Gabapentin	0.286	-2.712	Moderate	14 (4/10)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#A9C9E1	1.23849855051438	1
Rifampicin	Nifedipine	0.063	1.383	Major	5 (3/2)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#F8BABA	0.442320910897991	1
Haloperidol	Rifampicin	0.208	-1.085	Major	4 (2/2)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#B4D1E6	0.353856728718393	1
Clarithromycin	Quetiapine	0.19	1.119	Major	62 (34/28)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F9BCBC	5.48477929513509	1
Leflunomide	Acenocoumarol	0.258	Inf	None	2 (2/0)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.176928364359196	1
Dihydroergotamine	Bisoprolol	0.277	4.609	Moderate	6 (5/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#EEA4A4	0.530785093077589	1
Triamcinolone	Acetylsalicylic acid	0.446	1.347	Moderate	32 (19/13)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#F8BABA	2.83085382974714	1
Levofloxacin	Josamycin	0.742	3.38	None	14 (11/3)		#F2AEAE	1.23849855051438	1
Cyclosporine	Diltiazem	0.545	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#B32020	0.0884641821795982	1
Atorvastatin	Bezafibrate	0.552	-7.593	None	8 (1/7)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#8BB3D4	0.707713457436786	0.0268465343271904
Propranolol	Salmeterol	0.339	2.189	Major	27 (19/8)		#F6B6B6	2.38853291884915	1
Pentoxifylline	Acenocoumarol	0.239	-1.808	None	8 (3/5)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	0.707713457436786	1
Cyclosporine	Colchicine	0.255	-14.102	Major	14 (1/13)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#6294C2	1.23849855051438	2.25553676628129e-08
Fluvoxamine	Nortriptyline	0.586	-1.085	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#B4D1E6	0.176928364359196	1
Indomethacin	Bisoprolol	0.168	-1.326	Moderate	20 (9/11)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#B2D0E5	1.76928364359196	1
Fluoxetine	Doxepin	0.417	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#B32020	0.265392546538795	1
Carbamazepine	Acenocoumarol	0.392	-3.254	None	16 (4/12)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#A6C7E0	1.41542691487357	1
Trazodone	Acenocoumarol	0.205	1.844	None	9 (6/3)		#F7B7B7	0.796177639616384	1
Glyburide	Carvedilol	0.514	-2.17	Moderate	3 (1/2)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#AECDE3	0.265392546538795	1
Erythromycin	Zafirlukast	0.258	2.766	Moderate	4 (3/1)	The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.	#F4B1B1	0.353856728718393	1
Diazepam	Rifampicin	0.322	1.067	Minor	41 (22/19)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#F9BCBC	3.62703146936353	1
Phenytoin	Midazolam	0.136	-3.254	Moderate	4 (1/3)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#A6C7E0	0.353856728718393	1
Epinephrine	Doxepin	0.5	Inf	Major	1 (1/0)	Doxepin may decrease the antihypertensive activities of Epinephrine.	#B32020	0.0884641821795982	1
Warfarin	Isotretinoin	0.033	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Paroxetine	Pimozide	0.322	-2.983	Major	15 (4/11)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#A8C8E1	1.32696273269397	1
Trimethoprim	Methotrexate	0.217	1.076	Major	13 (7/6)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F9BCBC	1.15003436833478	1
Citalopram	Josamycin	0.071	4.302	None	17 (14/3)		#F0A7A7	1.50389109705317	1
Dihydroergotamine	Frovatriptan	0.591	Inf	Major	2 (2/0)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.176928364359196	1
Cyclosporine	Fluconazole	0.326	1.844	Moderate	12 (8/4)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#F7B7B7	1.06157018615518	1
Metoprolol	Ibuprofen	0.183	1.936	Moderate	31 (21/10)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F7B7B7	2.74238964756754	1
Sucralfate	Levothyroxine	0.204	6.914	Minor	17 (15/2)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#E89696	1.50389109705317	1
Atenolol	Insulin detemir	0.242	-1.808	Moderate	8 (3/5)		#AFCEE4	0.707713457436786	1
Sertraline	Carvedilol	0.331	-1.266	Moderate	13 (6/7)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#B2D0E5	1.15003436833478	1
Alprazolam	Ketoconazole	0.23	1.425	Major	28 (17/11)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F8BABA	2.47699710102875	1
Fludrocortisone	Rifampicin	0.027	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#B32020	0.0884641821795982	1
Acetylsalicylic acid	Glipizide	0.312	Inf	Moderate	1 (1/0)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#B32020	0.0884641821795982	1
Indomethacin	Atenolol	0.29	-2.305	Moderate	25 (8/17)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#ACCCE3	2.21160455448996	1
Lovastatin	Gemfibrozil	0.16	-1.085	Major	2 (1/1)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B4D1E6	0.176928364359196	1
Fluoxetine	Warfarin	0.214	4.609	Moderate	6 (5/1)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#EEA4A4	0.530785093077589	1
Itraconazole	Clarithromycin	0.579	2.135	Moderate	63 (44/19)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F6B6B6	5.57324347731469	1
Trandolapril	Tizanidine	0.024	Inf	Major	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B32020	0.0884641821795982	1
Cyclosporine	Mefenamic acid	0.359	Inf	Moderate	1 (1/0)	Mefenamic acid may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0884641821795982	1
Atenolol	Terbutaline	0.245	2.212	Moderate	17 (12/5)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#F5B4B4	1.50389109705317	1
Paroxetine	Naratriptan	0.185	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B32020	0.442320910897991	1
Chlorpromazine	Levofloxacin	0.2	1.844	Moderate	6 (4/2)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#F7B7B7	0.530785093077589	1
Propranolol	Verapamil	0.643	2.766	Major	4 (3/1)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F4B1B1	0.353856728718393	1
Tramadol	Moclobemide	0.478	Inf	None	2 (2/0)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#B32020	0.176928364359196	1
Metronidazole	Phenobarbital	0.085	-1.266	Moderate	13 (6/7)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#B2D0E5	1.15003436833478	1
Levofloxacin	Methotrimeprazine	0.099	-2.531	Moderate	30 (9/21)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#ABCBE2	2.65392546538795	1
Atenolol	Salmeterol	0.271	1.69	Moderate	17 (11/6)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#F7B9B9	1.50389109705317	1
Warfarin	Norfloxacin	0.075	Inf	Major	6 (6/0)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#B32020	0.530785093077589	1
Norfloxacin	Acenocoumarol	0.161	2.581	None	19 (14/5)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F5B2B2	1.68081946141237	1
Atenolol	Piroxicam	0.156	Inf	Moderate	2 (2/0)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#B32020	0.176928364359196	1
Citalopram	Frovatriptan	0.22	2.766	Major	12 (9/3)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#F4B1B1	1.06157018615518	1
Digoxin	Diazepam	0.289	1.659	Moderate	14 (9/5)		#F7B9B9	1.23849855051438	1
Chlorpromazine	Bromocriptine	0.281	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Bromocriptine.	#B32020	0.0884641821795982	1
Enalapril	Rifampicin	0.254	-2.712	None	21 (6/15)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#A9C9E1	1.85774782577156	1
Carbamazepine	Metronidazole	0.211	1.229	Moderate	21 (12/9)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F9BCBC	1.85774782577156	1
Bisoprolol	Salmeterol	0.196	-2.564	Moderate	37 (11/26)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#ABCBE2	3.27317474064513	1
Fentanyl	Rifampicin	0.356	-1.627	Major	5 (2/3)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B1CFE5	0.442320910897991	1
Diclofenac	Warfarin	0.224	-1.183	Major	23 (11/12)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B4D1E6	2.03467619013076	1
Hydrocortisone	Acetylsalicylic acid	0.39	-1.989	Moderate	51 (18/33)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#AECDE3	4.51167329115951	1
Citalopram	Carvedilol	0.317	-1.898	Moderate	22 (8/14)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#AFCEE4	1.94621200795116	1
Erythromycin	Methylprednisolone	0.775	1.997	Moderate	19 (13/6)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F6B6B6	1.68081946141237	1
Pyridostigmine	Methylprednisolone	0.611	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#B32020	0.176928364359196	1
Fluvoxamine	Eletriptan	0.344	Inf	Major	2 (2/0)	The serum concentration of Eletriptan can be increased when it is combined with Fluvoxamine.	#B32020	0.176928364359196	1
Risperidone	Itraconazole	0.164	-1.972	None	31 (11/20)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#AECDE3	2.74238964756754	1
Norfloxacin	Iron	0.448	13.644	None	79 (74/5)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#D46A6A	6.98867039218826	1
Testosterone	Acenocoumarol	0.346	-3.254	None	4 (1/3)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#A6C7E0	0.353856728718393	1
Carbamazepine	Ethinylestradiol	0.154	Inf	Major	19 (19/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Carbamazepine.	#B32020	1.68081946141237	1
Fluvoxamine	Tramadol	0.174	1.449	Major	18 (11/7)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F8BABA	1.59235527923277	1
Indomethacin	Furosemide	0.388	1.291	Moderate	12 (7/5)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#F8BABA	1.06157018615518	1
Erythromycin	Atorvastatin	0.19	-1.205	Major	19 (9/10)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#B4D1E6	1.68081946141237	1
Cyclosporine	Naproxen	0.188	1.257	Moderate	26 (15/11)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#F8BABA	2.30006873666955	1
Amitriptyline	Terbutaline	0.285	1.332	Moderate	44 (26/18)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F8BABA	3.89242401590232	1
Clozapine	Lisinopril	0.039	-1.085	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#B4D1E6	0.176928364359196	1
Labetalol	Gliclazide	0.214	Inf	None	3 (3/0)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#B32020	0.265392546538795	1
Erythromycin	Acenocoumarol	0.114	5.531	None	7 (6/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#EC9F9F	0.619249275257188	1
Diltiazem	Propranolol	0.351	Inf	Major	3 (3/0)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#B32020	0.265392546538795	1
Bisoprolol	Terbutaline	0.107	-1.676	Moderate	28 (11/17)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B1CFE5	2.47699710102875	1
Salmeterol	Carvedilol	0.393	-2.712	Major	14 (4/10)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#A9C9E1	1.23849855051438	1
Carbamazepine	Bupropion	0.145	-1.627	Moderate	10 (4/6)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#B1CFE5	0.884641821795982	1
Fluvastatin	Acenocoumarol	0.172	-1.085	None	2 (1/1)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#B4D1E6	0.176928364359196	1
Tacrolimus	Felodipine	0.083	Inf	Moderate	1 (1/0)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#B32020	0.0884641821795982	1
Phenytoin	Prednisone	0.267	-1.55	Moderate	17 (7/10)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B1CFE5	1.50389109705317	1
Atorvastatin	Itraconazole	0.198	-1.578	Major	27 (11/16)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B1CFE5	2.38853291884915	1
Ergotamine	Clarithromycin	0.514	1.959	Major	25 (17/8)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F6B6B6	2.21160455448996	1
Atenolol	Formoterol	0.287	-1.085	Moderate	30 (15/15)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B4D1E6	2.65392546538795	1
Ranolazine	Clarithromycin	0.143	Inf	Major	1 (1/0)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#B32020	0.0884641821795982	1
Doxycycline	Carbamazepine	0.139	-1.085	Moderate	16 (8/8)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#B4D1E6	1.41542691487357	1
Desogestrel	Lamotrigine	0.174	Inf	Moderate	18 (18/0)	Desogestrel may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.	#B32020	1.59235527923277	1
Clarithromycin	Acenocoumarol	0.072	1.712	None	20 (13/7)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#F7B9B9	1.76928364359196	1
Ramipril	Tizanidine	0.296	1.152	Major	9 (5/4)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#F9BCBC	0.796177639616384	1
Lovastatin	Carbamazepine	0.359	-2.17	None	3 (1/2)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#AECDE3	0.265392546538795	1
Azithromycin	Warfarin	0.105	2.458	Moderate	11 (8/3)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#F5B2B2	0.97310600397558	1
Tacrolimus	Itraconazole	0.597	1.127	Major	20 (11/9)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#F9BCBC	1.76928364359196	1
Phenoxymethylpenicillin	Methotrexate	0.083	Inf	Major	9 (9/0)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#B32020	0.796177639616384	1
Metoprolol	Lidocaine	0.053	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#B32020	0.0884641821795982	1
Omeprazole	Quazepam	0.115	-1.085	Moderate	10 (5/5)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#B4D1E6	0.884641821795982	1
Atorvastatin	Clarithromycin	0.146	-2.626	Major	65 (19/46)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#ABCBE2	5.75017184167388	1
Fluvoxamine	Dihydroergotamine	0.287	1.844	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#F7B7B7	0.265392546538795	1
Phenytoin	Ciprofloxacin	0.14	-3.073	Moderate	23 (6/17)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#A8C8E1	2.03467619013076	1
Fluvoxamine	Sumatriptan	0.121	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B32020	0.353856728718393	1
Spironolactone	Irbesartan	0.231	-4.339	Major	5 (1/4)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#A0C3DD	0.442320910897991	1
Naproxen	Acenocoumarol	0.155	1.067	None	41 (22/19)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	3.62703146936353	1
Hydrocortisone	Primidone	0.083	Inf	Moderate	1 (1/0)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#B32020	0.0884641821795982	1
Doxycycline	Iron	0.515	7.836	Moderate	38 (34/4)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#E59090	3.36163892282473	1
Fluvastatin	Gemfibrozil	0.473	-3.254	Major	4 (1/3)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#A6C7E0	0.353856728718393	1
Tizanidine	Norethisterone	0.427	Inf	Major	8 (8/0)		#B32020	0.707713457436786	1
Erythromycin	Cabergoline	0.716	Inf	Major	14 (14/0)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#B32020	1.23849855051438	1
Lidocaine	Nadolol	0.193	Inf	Moderate	2 (2/0)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#B32020	0.176928364359196	1
Fenofibrate	Acenocoumarol	0.413	-6.509	None	14 (2/12)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#91B7D7	1.23849855051438	1
Ranitidine	Itraconazole	0.409	1.485	Moderate	47 (29/18)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F7B9B9	4.15781656244112	1
Glimepiride	Gemfibrozil	0.377	-14.102	Moderate	14 (1/13)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#6294C2	1.23849855051438	0.000510871876441774
Eletriptan	Clarithromycin	0.174	Inf	Major	11 (11/0)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#B32020	0.97310600397558	1
Trospium	Olanzapine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Prednisone	Ketoconazole	0.688	2.766	Moderate	16 (12/4)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#F4B1B1	1.41542691487357	1
Itraconazole	Aripiprazole	0.089	1.383	Moderate	15 (9/6)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#F8BABA	1.32696273269397	1
Ketoconazole	Quetiapine	0.159	3.687	Major	5 (4/1)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#F1ABAB	0.442320910897991	1
Bisoprolol	Epinephrine	0.374	Inf	Moderate	5 (5/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B32020	0.442320910897991	1
Levofloxacin	Iron	0.457	7.221	Moderate	53 (47/6)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#E79494	4.68860165551871	1
Glimepiride	Pregabalin	0.434	1.383	None	5 (3/2)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#F8BABA	0.442320910897991	1
Morphine	Rifampicin	0.537	-2.17	Moderate	3 (1/2)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#AECDE3	0.265392546538795	1
Citalopram	Naratriptan	0.098	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.353856728718393	1
Trazodone	Itraconazole	0.324	2.397	Moderate	18 (13/5)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F5B4B4	1.59235527923277	1
Metoprolol	Dihydroergotamine	0.018	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.0884641821795982	1
Torasemide	Indomethacin	0.309	Inf	Moderate	4 (4/0)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B32020	0.353856728718393	1
Naratriptan	Escitalopram	0.401	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#B32020	0.265392546538795	1
Estradiol	Ursodeoxycholic acid	0.505	Inf	None	7 (7/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B32020	0.619249275257188	1
Ethinylestradiol	Rifampicin	0.292	Inf	Major	10 (10/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Rifampicin.	#B32020	0.884641821795982	1
Methotrexate	Sulfamethoxazole	0.261	-1.085	Moderate	10 (5/5)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#B4D1E6	0.884641821795982	1
Sumatriptan	Lithium cation	0.184	-3.688	None	22 (5/17)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#A3C5DF	1.94621200795116	1
Diazepam	Josamycin	0.347	2.305	None	28 (20/8)		#F5B4B4	2.47699710102875	1
Clozapine	Alprazolam	0.312	-1.519	Major	12 (5/7)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#B1CFE5	1.06157018615518	1
Fludrocortisone	Acetylsalicylic acid	0.48	-1.808	Moderate	8 (3/5)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#AFCEE4	0.707713457436786	1
Lidocaine	Propranolol	0.115	2.305	Moderate	7 (5/2)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F5B4B4	0.619249275257188	1
Fludrocortisone	Acenocoumarol	0.404	Inf	None	1 (1/0)		#B32020	0.0884641821795982	1
Trospium	Amitriptyline	0.217	Inf	Moderate	2 (2/0)		#B32020	0.176928364359196	1
Phenobarbital	Dexamethasone	0.238	-1.627	Moderate	5 (2/3)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B1CFE5	0.442320910897991	1
Levothyroxine	Raloxifene	0.218	1.383	Moderate	5 (3/2)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F8BABA	0.442320910897991	1
Prednisolone	Phenobarbital	0.023	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be decreased when it is combined with Phenobarbital.	#B32020	0.0884641821795982	1
Propranolol	Hydralazine	0.292	Inf	Minor	3 (3/0)	Hydralazine may increase the hypotensive activities of Propranolol.	#B32020	0.265392546538795	1
Doxycycline	Cloxacillin	0.63	-1.464	Moderate	47 (20/27)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#B2D0E5	4.15781656244112	1
Losartan	Rifampicin	0.073	-2.17	Moderate	6 (2/4)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#AECDE3	0.530785093077589	1
Fluconazole	Ergotamine	0.348	11.062	Moderate	13 (12/1)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#DB7A7A	1.15003436833478	1
Sertraline	Moclobemide	0.02	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Sertraline is combined with Moclobemide.	#B32020	0.0884641821795982	1
Salbutamol	Moclobemide	0.162	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#B32020	0.176928364359196	1
Amitriptyline	Pseudoephedrine	0.379	3.534	None	29 (23/6)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F2ACAC	2.56546128320835	1
Gliclazide	Carvedilol	0.406	-4.339	None	5 (1/4)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#A0C3DD	0.442320910897991	1
Moxifloxacin	Warfarin	0.148	1.844	Major	3 (2/1)		#F7B7B7	0.265392546538795	1
Alprazolam	Josamycin	0.279	2.581	None	19 (14/5)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F5B2B2	1.68081946141237	1
Fluoxetine	Propafenone	0.15	Inf	Moderate	2 (2/0)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#B32020	0.176928364359196	1
Labetalol	Salmeterol	0.194	7.375	Major	9 (8/1)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#E69393	0.796177639616384	1
Phenytoin	Methylprednisolone	0.434	-2.17	Moderate	6 (2/4)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#AECDE3	0.530785093077589	1
Doxycycline	Insulin aspart	0.142	-1.085	Moderate	18 (9/9)		#B4D1E6	1.59235527923277	1
Warfarin	Naproxen	0.064	3.687	Major	10 (8/2)	Naproxen may increase the anticoagulant activities of Warfarin.	#F1ABAB	0.884641821795982	1
Erythromycin	Sirolimus	0.033	Inf	Major	1 (1/0)	The metabolism of Sirolimus can be decreased when combined with Erythromycin.	#B32020	0.0884641821795982	1
Formoterol	Carvedilol	0.272	-1.736	Major	13 (5/8)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#AFCEE4	1.15003436833478	1
Terbinafine	Acenocoumarol	0.129	-1.356	None	9 (4/5)		#B2D0E5	0.796177639616384	1
Terbutaline	Clomipramine	0.145	-1.763	Moderate	21 (8/13)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#AFCEE4	1.85774782577156	1
Amitriptyline	Moclobemide	0.192	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.0884641821795982	1
Amitriptyline	Epinephrine	0.341	1.844	Major	15 (10/5)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#F7B7B7	1.32696273269397	1
Lansoprazole	Itraconazole	0.255	1.229	Moderate	21 (12/9)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F9BCBC	1.85774782577156	1
Metoclopramide	Levodopa	0.401	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#B32020	0.265392546538795	1
Clarithromycin	Solifenacin	0.251	1.844	Major	15 (10/5)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F7B7B7	1.32696273269397	1
Dihydroergotamine	Atenolol	0.365	-1.085	Moderate	6 (3/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B4D1E6	0.530785093077589	1
Phenytoin	Medroxyprogesterone acetate	0.211	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Phenytoin.	#B32020	0.176928364359196	1
Trospium	Quetiapine	0.2	-2.17	Moderate	3 (1/2)		#AECDE3	0.265392546538795	1
Norethisterone	Phenobarbital	0.135	Inf	Major	2 (2/0)	The metabolism of Norethisterone can be increased when combined with Phenobarbital.	#B32020	0.176928364359196	1
Warfarin	Levofloxacin	0.242	1.383	Major	5 (3/2)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#F8BABA	0.442320910897991	1
Sucralfate	Ciprofloxacin	0.511	1.152	Moderate	18 (10/8)		#F9BCBC	1.59235527923277	1
Phenytoin	Sertraline	0.402	-3.254	Moderate	12 (3/9)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#A6C7E0	1.06157018615518	1
Alprazolam	Telithromycin	0.183	Inf	Moderate	3 (3/0)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#B32020	0.265392546538795	1
Dextromethorphan	Terbinafine	0.45	2.107	Major	23 (16/7)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F6B6B6	2.03467619013076	1
Piroxicam	Lithium cation	0.3	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Piroxicam.	#B32020	0.0884641821795982	1
Erythromycin	Quetiapine	0.237	-1.205	Major	19 (9/10)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#B4D1E6	1.68081946141237	1
Doxycycline	Phenobarbital	0.068	-1.085	Moderate	6 (3/3)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.530785093077589	1
Citalopram	Metoprolol	0.257	1.844	Moderate	6 (4/2)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F7B7B7	0.530785093077589	1
Phenytoin	Mirtazapine	0.185	-6.509	Moderate	14 (2/12)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#91B7D7	1.23849855051438	1
Colestipol	Levothyroxine	0.211	-1.085	Moderate	4 (2/2)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#B4D1E6	0.353856728718393	1
Dihydroergotamine	Clarithromycin	0.559	4.609	Major	12 (10/2)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#EEA4A4	1.06157018615518	1
Clarithromycin	Colchicine	0.461	1.152	Major	9 (5/4)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#F9BCBC	0.796177639616384	1
Carbamazepine	Norethisterone	0.221	Inf	Major	4 (4/0)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#B32020	0.353856728718393	1
Nortriptyline	Terbutaline	0.087	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#B32020	0.176928364359196	1
Folic acid	Primidone	0.187	1.844	Moderate	3 (2/1)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#F7B7B7	0.265392546538795	1
Carbamazepine	Itraconazole	0.09	2.151	Moderate	10 (7/3)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F6B6B6	0.884641821795982	1
Pantoprazole	Ketoconazole	0.396	1.229	Moderate	7 (4/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#F9BCBC	0.619249275257188	1
Doxycycline	Benzylpenicillin	1	-2.17	Moderate	3 (1/2)	The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Doxycycline.	#AECDE3	0.265392546538795	1
Prednisone	Phenobarbital	0.181	-1.395	Moderate	16 (7/9)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B2D0E5	1.41542691487357	1
Isotretinoin	Minocycline	0.338	-1.627	Major	5 (2/3)	The risk or severity of adverse effects can be increased when Minocycline is combined with Isotretinoin.	#B1CFE5	0.442320910897991	1
Propranolol	Terbutaline	0.244	1.383	Major	20 (12/8)		#F8BABA	1.76928364359196	1
Simvastatin	Telithromycin	0.5	Inf	Major	1 (1/0)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#B32020	0.0884641821795982	1
Indomethacin	Nadolol	0.296	1.383	Moderate	5 (3/2)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#F8BABA	0.442320910897991	1
Disulfiram	Metronidazole	0.158	-1.266	Major	13 (6/7)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#B2D0E5	1.15003436833478	1
Labetalol	Formoterol	0.117	Inf	Major	11 (11/0)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B32020	0.97310600397558	1
Tetracycline	Insulin aspart	0.107	2.766	Moderate	4 (3/1)		#F4B1B1	0.353856728718393	1
Duloxetine	Propafenone	0.2	Inf	Moderate	1 (1/0)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#B32020	0.0884641821795982	1
Hydrocortisone	Acenocoumarol	0.522	1.229	None	7 (4/3)		#F9BCBC	0.619249275257188	1
Carbamazepine	Clarithromycin	0.176	1.229	Major	21 (12/9)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F9BCBC	1.85774782577156	1
Methylprednisolone	Itraconazole	0.5	1.449	Major	18 (11/7)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#F8BABA	1.59235527923277	1
Levonorgestrel	Carbamazepine	0.166	Inf	Major	11 (11/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Carbamazepine.	#B32020	0.97310600397558	1
Cimetidine	Diazepam	0.333	Inf	Moderate	3 (3/0)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#B32020	0.265392546538795	1
Frovatriptan	Sertraline	0.089	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.353856728718393	1
Terbutaline	Carvedilol	0.128	2.766	Major	4 (3/1)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#F4B1B1	0.353856728718393	1
Fluconazole	Haloperidol	0.208	1.844	Major	9 (6/3)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#F7B7B7	0.796177639616384	1
Sotalol	Clarithromycin	0.146	1.844	Major	3 (2/1)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#F7B7B7	0.265392546538795	1
Sertraline	Cilostazol	0.1	Inf	Moderate	1 (1/0)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#B32020	0.0884641821795982	1
Rifampicin	Dexamethasone	0.711	-2.17	Moderate	6 (2/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#AECDE3	0.530785093077589	1
Metoprolol	Formoterol	0.264	1.383	Moderate	5 (3/2)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#F8BABA	0.442320910897991	1
Doxycycline	Insulin detemir	0.368	Inf	Moderate	3 (3/0)		#B32020	0.265392546538795	1
Metoprolol	Fluoxetine	0.134	Inf	Moderate	3 (3/0)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#B32020	0.265392546538795	1
Ketoconazole	Clonazepam	0.101	1.844	None	6 (4/2)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#F7B7B7	0.530785093077589	1
Rifampicin	Clarithromycin	0.551	-1.085	Moderate	14 (7/7)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#B4D1E6	1.23849855051438	1
Haloperidol	Itraconazole	0.161	-1.356	Moderate	9 (4/5)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#B2D0E5	0.796177639616384	1
Flurazepam	Itraconazole	0.215	Inf	None	3 (3/0)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#B32020	0.265392546538795	1
Dextromethorphan	Moclobemide	0.333	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Dextromethorphan.	#B32020	0.0884641821795982	1
Dihydroergotamine	Itraconazole	0.598	2.305	Major	7 (5/2)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#F5B4B4	0.619249275257188	1
Lidocaine	Carvedilol	0.048	-1.085	Moderate	2 (1/1)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#B4D1E6	0.176928364359196	1
Cyclosporine	Ethinylestradiol	0.145	Inf	Moderate	6 (6/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Cyclosporine.	#B32020	0.530785093077589	1
Rifampicin	Atorvastatin	0.674	1.844	Major	3 (2/1)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#F7B7B7	0.265392546538795	1
Bumetanide	Ibuprofen	0.095	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#B32020	0.265392546538795	1
Phenytoin	Clarithromycin	0.091	-1.627	Moderate	10 (4/6)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B1CFE5	0.884641821795982	1
Naratriptan	Sertraline	0.275	1.844	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#F7B7B7	0.265392546538795	1
Midazolam	Ketoconazole	0.333	Inf	Major	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.	#B32020	0.0884641821795982	1
Mefenamic acid	Lithium cation	0.154	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Mefenamic acid.	#B32020	0.0884641821795982	1
Rifampicin	Gliclazide	0.077	Inf	None	1 (1/0)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#B32020	0.0884641821795982	1
Epinephrine	Nadolol	0.119	Inf	Major	2 (2/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.176928364359196	1
Cyclosporine	Terbinafine	0.096	1.844	Minor	3 (2/1)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#F7B7B7	0.265392546538795	1
Ketoconazole	Tolterodine	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#B32020	0.0884641821795982	1
Cyclosporine	Methylphenidate	0.333	Inf	Minor	1 (1/0)		#B32020	0.0884641821795982	1
Propranolol	Glyburide	0.088	1.844	Moderate	3 (2/1)	Propranolol may increase the hypoglycemic activities of Glyburide.	#F7B7B7	0.265392546538795	1
Tacrolimus	Clarithromycin	0.503	1.089	Major	24 (13/11)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F9BCBC	2.12314037231036	1
Atenolol	Repaglinide	0.3	-3.254	Moderate	4 (1/3)		#A6C7E0	0.353856728718393	1
Phenobarbital	Acenocoumarol	0.264	-5.424	None	6 (1/5)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#99BDDA	0.530785093077589	1
Trazodone	Ginkgo biloba	0.227	-1.627	Moderate	5 (2/3)		#B1CFE5	0.442320910897991	1
Tetracycline	Amoxicillin	0.568	2.561	Moderate	34 (25/9)		#F5B2B2	3.00778219410634	1
Almotriptan	Itraconazole	0.289	6.453	Moderate	8 (7/1)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#E99999	0.707713457436786	1
Methotrexate	Cloxacillin	0.151	-1.22	Major	17 (8/9)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#B4D1E6	1.50389109705317	1
Cyclosporine	Fluoxetine	0.346	1.229	Moderate	7 (4/3)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F9BCBC	0.619249275257188	1
Phenytoin	Methotrexate	0.1	-1.085	Moderate	2 (1/1)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#B4D1E6	0.176928364359196	1
Theophylline	Carbamazepine	0.517	-1.085	Moderate	2 (1/1)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#B4D1E6	0.176928364359196	1
Fluconazole	Flurazepam	0.219	3.687	None	5 (4/1)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#F1ABAB	0.442320910897991	1
Alprazolam	Cimetidine	0.545	Inf	Moderate	2 (2/0)		#B32020	0.176928364359196	1
Fluconazole	Celecoxib	0.554	5.531	Moderate	14 (12/2)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#EC9F9F	1.23849855051438	1
Diazepam	Ketoconazole	0.359	1.229	Moderate	21 (12/9)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F9BCBC	1.85774782577156	1
Losartan	Lithium cation	0.431	-2.17	Moderate	6 (2/4)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#AECDE3	0.530785093077589	1
Bisoprolol	Repaglinide	0.315	-2.17	Moderate	3 (1/2)		#AECDE3	0.265392546538795	1
Acenocoumarol	Etoricoxib	0.245	2.766	None	4 (3/1)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#F4B1B1	0.353856728718393	1
Indapamide	Lithium cation	0.118	-2.17	Major	3 (1/2)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#AECDE3	0.265392546538795	1
Ibandronate	Iron	0.244	Inf	Moderate	3 (3/0)		#B32020	0.265392546538795	1
Fluoxetine	Josamycin	0.106	2.766	None	8 (6/2)		#F4B1B1	0.707713457436786	1
Tacrolimus	Ketoconazole	0.146	Inf	Major	2 (2/0)	The serum concentration of Tacrolimus can be increased when it is combined with Ketoconazole.	#B32020	0.176928364359196	1
Lisinopril	Drospirenone	0.299	Inf	Moderate	5 (5/0)	Lisinopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.442320910897991	1
Cyclosporine	Diclofenac	0.139	-1.326	Moderate	20 (9/11)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	1.76928364359196	1
Lisinopril	Lithium cation	0.13	1.844	Moderate	3 (2/1)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#F7B7B7	0.265392546538795	1
Eletriptan	Itraconazole	0.068	Inf	Major	4 (4/0)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#B32020	0.353856728718393	1
Moxifloxacin	Ziprasidone	0.059	-1.627	Major	5 (2/3)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B1CFE5	0.442320910897991	1
Citalopram	Pimozide	0.42	-1.627	Major	5 (2/3)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#B1CFE5	0.442320910897991	1
Celecoxib	Lithium cation	0.159	1.383	Major	5 (3/2)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F8BABA	0.442320910897991	1
Fluconazole	Halazepam	0.287	Inf	None	4 (4/0)		#B32020	0.353856728718393	1
Fluconazole	Rifampicin	0.608	1.152	Major	9 (5/4)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#F9BCBC	0.796177639616384	1
Erythromycin	Itraconazole	0.647	2.305	Major	14 (10/4)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#F5B4B4	1.23849855051438	1
Labetalol	Verapamil	0.333	Inf	Major	1 (1/0)	Verapamil may increase the hypotensive activities of Labetalol.	#B32020	0.0884641821795982	1
Bisoprolol	Ergotamine	0.642	2.766	Moderate	4 (3/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F4B1B1	0.353856728718393	1
Atomoxetine	Paroxetine	0.164	-1.627	Major	5 (2/3)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#B1CFE5	0.442320910897991	1
Ramipril	Drospirenone	0.303	Inf	Moderate	4 (4/0)	Ramipril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.353856728718393	1
Medroxyprogesterone acetate	Phenobarbital	0.427	Inf	Moderate	2 (2/0)	The metabolism of Medroxyprogesterone acetate can be increased when combined with Phenobarbital.	#B32020	0.176928364359196	1
Rabeprazole	Itraconazole	0.507	1.076	Moderate	13 (7/6)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F9BCBC	1.15003436833478	1
Metronidazole	Acenocoumarol	0.221	1.536	None	8 (5/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#F7B9B9	0.707713457436786	1
Cyclosporine	Oxcarbazepine	0.214	-1.085	Moderate	2 (1/1)		#B4D1E6	0.176928364359196	1
Pyridostigmine	Triamcinolone	0.143	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.	#B32020	0.0884641821795982	1
Ciprofloxacin	Tizanidine	0.321	-2.034	Major	46 (16/30)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#AECDE3	4.06935238026152	1
Warfarin	Paroxetine	0.367	Inf	Moderate	3 (3/0)	Paroxetine may increase the anticoagulant activities of Warfarin.	#B32020	0.265392546538795	1
Itraconazole	Solifenacin	0.237	Inf	Major	4 (4/0)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#B32020	0.353856728718393	1
Tolterodine	Itraconazole	0.408	2.766	Moderate	4 (3/1)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F4B1B1	0.353856728718393	1
Phenytoin	Tacrolimus	0.112	-2.17	Major	3 (1/2)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#AECDE3	0.265392546538795	1
Pseudoephedrine	Clomipramine	0.228	-1.446	None	14 (6/8)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B2D0E5	1.23849855051438	1
Sotalol	Ibuprofen	0.163	-1.953	Moderate	14 (5/9)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#AFCEE4	1.23849855051438	1
Ranitidine	Ketoconazole	0.256	Inf	Moderate	5 (5/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#B32020	0.442320910897991	1
Telmisartan	Drospirenone	0.137	Inf	Moderate	2 (2/0)	Telmisartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.176928364359196	1
Repaglinide	Clarithromycin	0.254	-1.085	Moderate	6 (3/3)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#B4D1E6	0.530785093077589	1
Fluoxetine	Naratriptan	0.246	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#B32020	0.176928364359196	1
Lidocaine	Atenolol	0.318	-1.085	Moderate	4 (2/2)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#B4D1E6	0.353856728718393	1
Indomethacin	Losartan	0.244	-2.893	Moderate	11 (3/8)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#A9C9E1	0.97310600397558	1
Minocycline	Iron	0.258	10.141	Moderate	12 (11/1)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#DE8080	1.06157018615518	1
Warfarin	Metronidazole	0.286	Inf	Major	2 (2/0)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#B32020	0.176928364359196	1
Metoprolol	Salbutamol	0.287	Inf	Moderate	4 (4/0)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B32020	0.353856728718393	1
Minocycline	Cloxacillin	0.527	-2.17	Moderate	21 (7/14)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#AECDE3	1.85774782577156	1
Erythromycin	Lovastatin	0.111	-1.085	Major	2 (1/1)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#B4D1E6	0.176928364359196	1
Diclofenac	Rifampicin	0.428	-2.386	Moderate	32 (10/22)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#ACCCE3	2.83085382974714	1
Nifedipine	Phenobarbital	0.25	Inf	Major	1 (1/0)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#B32020	0.0884641821795982	1
Erythromycin	Amiodarone	0.039	-1.085	Major	2 (1/1)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	0.176928364359196	1
Dexamethasone	Acenocoumarol	0.251	1.844	None	3 (2/1)		#F7B7B7	0.265392546538795	1
Prednisolone	Acetylsalicylic acid	0.19	2.766	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#F4B1B1	0.353856728718393	1
Lidocaine	Bisoprolol	0.14	1.844	Moderate	3 (2/1)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F7B7B7	0.265392546538795	1
Prednisolone	Acenocoumarol	0.062	Inf	None	1 (1/0)		#B32020	0.0884641821795982	1
Tacrolimus	Metronidazole	0.37	1.291	Moderate	12 (7/5)		#F8BABA	1.06157018615518	1
Dihydroergotamine	Labetalol	0.5	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.176928364359196	1
Phenytoin	Norethisterone	0.5	Inf	None	1 (1/0)	The metabolism of Norethisterone can be increased when combined with Phenytoin.	#B32020	0.0884641821795982	1
Atorvastatin	Colchicine	0.272	-16.271	Major	16 (1/15)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#548ABC	1.41542691487357	1
Ergotamine	Itraconazole	0.144	4.609	Major	6 (5/1)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#EEA4A4	0.530785093077589	1
Ropinirole	Ciprofloxacin	0.023	Inf	Moderate	2 (2/0)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B32020	0.176928364359196	1
Triamcinolone	Rifampicin	0.521	Inf	Moderate	2 (2/0)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#B32020	0.176928364359196	1
Fluconazole	Imipramine	0.087	Inf	Moderate	3 (3/0)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#B32020	0.265392546538795	1
Fluconazole	Tolterodine	0.627	-1.085	Moderate	8 (4/4)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#B4D1E6	0.707713457436786	1
Diltiazem	Tacrolimus	0.373	-7.593	Moderate	8 (1/7)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#8BB3D4	0.707713457436786	1
Doxycycline	Insulin glulisine	0.055	-1.085	Moderate	4 (2/2)		#B4D1E6	0.353856728718393	1
Griseofulvin	Estradiol	0.143	Inf	Moderate	1 (1/0)	The metabolism of Estradiol can be increased when combined with Griseofulvin.	#B32020	0.0884641821795982	1
Sotalol	Levofloxacin	0.058	-4.339	Major	5 (1/4)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#A0C3DD	0.442320910897991	1
Clozapine	Norfloxacin	0.268	Inf	Major	2 (2/0)	Norfloxacin may increase the QTc-prolonging activities of Clozapine.	#B32020	0.176928364359196	1
Fentanyl	Ketoconazole	0.071	Inf	Major	1 (1/0)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B32020	0.0884641821795982	1
Fenofibrate	Ursodeoxycholic acid	0.681	-3.254	None	4 (1/3)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#A6C7E0	0.353856728718393	1
Metoprolol	Indomethacin	0.509	-1.085	Moderate	2 (1/1)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#B4D1E6	0.176928364359196	1
Rifampicin	Acenocoumarol	0.034	-1.085	None	2 (1/1)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#B4D1E6	0.176928364359196	1
Estradiol	Prednisolone	0.363	Inf	Moderate	3 (3/0)	The serum concentration of Prednisolone can be increased when it is combined with Estradiol.	#B32020	0.265392546538795	1
Cyclosporine	Carbamazepine	0.118	Inf	Major	1 (1/0)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#B32020	0.0884641821795982	1
Salbutamol	Doxepin	0.13	-1.085	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#B4D1E6	0.353856728718393	1
Ketoconazole	Solifenacin	0.333	Inf	Major	1 (1/0)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#B32020	0.0884641821795982	1
Imipramine	Pseudoephedrine	0.087	Inf	None	2 (2/0)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.176928364359196	1
Warfarin	Etoricoxib	0.333	Inf	None	1 (1/0)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#B32020	0.0884641821795982	1
Captopril	Drospirenone	0.667	Inf	Moderate	2 (2/0)	Captopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.176928364359196	1
Methylprednisolone	Rifampicin	0.296	-1.627	Moderate	5 (2/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B1CFE5	0.442320910897991	1
Salbutamol	Rasagiline	0.091	-2.17	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#AECDE3	0.265392546538795	1
Propranolol	Maprotiline	0.255	-3.254	Minor	4 (1/3)		#A6C7E0	0.353856728718393	1
Trospium	Desloratadine	0.246	-1.085	None	2 (1/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#B4D1E6	0.176928364359196	1
Omeprazole	Triazolam	0.176	-3.977	Moderate	14 (3/11)		#A2C4DE	1.23849855051438	1
Pregabalin	Pioglitazone	0.215	-1.085	Moderate	2 (1/1)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#B4D1E6	0.176928364359196	1
Fluconazole	Cyclophosphamide	0.167	Inf	None	1 (1/0)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#B32020	0.0884641821795982	1
Clarithromycin	Everolimus	0.021	Inf	Major	1 (1/0)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#B32020	0.0884641821795982	1
Fluconazole	Dihydroergotamine	0.655	2.305	Moderate	7 (5/2)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#F5B4B4	0.619249275257188	1
Nabumetone	Methotrexate	0.096	-2.17	Major	3 (1/2)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#AECDE3	0.265392546538795	1
Salbutamol	Nadolol	0.186	-1.085	Major	14 (7/7)		#B4D1E6	1.23849855051438	1
Ampicillin	Ethinylestradiol	0.46	Inf	Moderate	4 (4/0)		#B32020	0.353856728718393	1
Ethinylestradiol	Phenobarbital	0.049	Inf	Major	4 (4/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Phenobarbital.	#B32020	0.353856728718393	1
Atenolol	Insulin aspart	0.207	-2.893	Moderate	11 (3/8)		#A9C9E1	0.97310600397558	1
Nortriptyline	Salbutamol	0.123	2.766	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#F4B1B1	0.353856728718393	1
Sotalol	Formoterol	0.5	Inf	Major	1 (1/0)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B32020	0.0884641821795982	1
Trospium	Cetirizine	0.177	-1.085	None	4 (2/2)		#B4D1E6	0.353856728718393	1
Ethinylestradiol	Ursodeoxycholic acid	0.18	Inf	None	6 (6/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.530785093077589	1
Doxycycline	Methotrexate	0.172	-1.898	Moderate	11 (4/7)		#AFCEE4	0.97310600397558	1
Formoterol	Nadolol	0.129	Inf	Major	4 (4/0)		#B32020	0.353856728718393	1
Fluphenazine	Levofloxacin	0.562	-1.085	Moderate	2 (1/1)		#B4D1E6	0.176928364359196	1
Tamoxifen	Rifampicin	0.118	Inf	Moderate	1 (1/0)	The metabolism of Tamoxifen can be increased when combined with Rifampicin.	#B32020	0.0884641821795982	1
Codeine	Naltrexone	0.187	-1.898	Major	11 (4/7)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#AFCEE4	0.97310600397558	1
Bromocriptine	Josamycin	1	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Josamycin.	#B32020	0.0884641821795982	1
Erythromycin	Rifampicin	0.289	1.844	Moderate	3 (2/1)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#F7B7B7	0.265392546538795	1
Modafinil	Ethinylestradiol	0.408	Inf	Moderate	2 (2/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Modafinil.	#B32020	0.176928364359196	1
Itraconazole	Phenobarbital	0.146	-1.627	Moderate	5 (2/3)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#B1CFE5	0.442320910897991	1
Propranolol	Gliclazide	0.303	-1.627	None	5 (2/3)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	0.442320910897991	1
Halazepam	Itraconazole	0.041	Inf	None	2 (2/0)		#B32020	0.176928364359196	1
Celecoxib	Acenocoumarol	0.414	-1.085	None	4 (2/2)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.353856728718393	1
Atenolol	Insulin glulisine	0.237	-2.17	Moderate	3 (1/2)		#AECDE3	0.265392546538795	1
Cloxacillin	Acenocoumarol	0.121	-3.254	None	16 (4/12)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#A6C7E0	1.41542691487357	1
Perphenazine	Levofloxacin	0.06	-1.085	Moderate	4 (2/2)		#B4D1E6	0.353856728718393	1
Midazolam	Clarithromycin	0.263	-1.356	Moderate	9 (4/5)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#B2D0E5	0.796177639616384	1
Indomethacin	Acenocoumarol	0.137	-2.712	None	7 (2/5)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	0.619249275257188	1
Fluvoxamine	Zolmitriptan	0.042	1.844	Moderate	3 (2/1)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#F7B7B7	0.265392546538795	1
Theophylline	Ethinylestradiol	0.152	Inf	None	3 (3/0)	The serum concentration of Theophylline can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.265392546538795	1
Lovastatin	Itraconazole	0.2	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#B32020	0.0884641821795982	1
Ethinylestradiol	Ketoconazole	0.35	Inf	Moderate	5 (5/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Ketoconazole.	#B32020	0.442320910897991	1
Medroxyprogesterone acetate	Warfarin	0.412	Inf	None	1 (1/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Warfarin.	#B32020	0.0884641821795982	1
Bisoprolol	Insulin glulisine	0.267	-4.339	Moderate	5 (1/4)		#A0C3DD	0.442320910897991	1
Fluvoxamine	Rizatriptan	0.567	Inf	Major	2 (2/0)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.176928364359196	1
Tetracycline	Acenocoumarol	0.205	-1.085	None	2 (1/1)		#B4D1E6	0.176928364359196	1
Doxycycline	Isotretinoin	0.292	-1.085	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#B4D1E6	0.353856728718393	1
Duloxetine	Flecainide	0.211	-1.085	Moderate	2 (1/1)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#B4D1E6	0.176928364359196	1
Cyclosporine	Clindamycin	0.492	1.844	Moderate	3 (2/1)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#F7B7B7	0.265392546538795	1
Carbamazepine	Isotretinoin	0.022	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Methotrexate	Ketoprofen	0.5	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#B32020	0.0884641821795982	1
Gemfibrozil	Ursodeoxycholic acid	0.251	-2.17	None	3 (1/2)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#AECDE3	0.265392546538795	1
Prednisolone	Ethinylestradiol	0.14	Inf	Moderate	4 (4/0)	The serum concentration of Prednisolone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.353856728718393	1
Labetalol	Terbutaline	0.101	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#B32020	0.353856728718393	1
Midazolam	Itraconazole	0.517	-1.085	Major	4 (2/2)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#B4D1E6	0.353856728718393	1
Lithium cation	Etoricoxib	0.052	-1.627	None	5 (2/3)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#B1CFE5	0.442320910897991	1
Metoprolol	Paroxetine	0.544	Inf	Moderate	2 (2/0)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#B32020	0.176928364359196	1
Erythromycin	Bromocriptine	1	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Erythromycin.	#B32020	0.176928364359196	1
Losartan	Drospirenone	0.154	Inf	Moderate	3 (3/0)	Losartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.265392546538795	1
Fluconazole	Acenocoumarol	0.174	-1.627	None	10 (4/6)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B1CFE5	0.884641821795982	1
Prednisolone	Itraconazole	0.583	1.844	Moderate	3 (2/1)	The serum concentration of Prednisolone can be increased when it is combined with Itraconazole.	#F7B7B7	0.265392546538795	1
Tetracycline	Iron	0.655	2.305	Moderate	7 (5/2)		#F5B4B4	0.619249275257188	1
Carbamazepine	Ketoconazole	0.037	-1.085	Moderate	2 (1/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#B4D1E6	0.176928364359196	1
Cyproheptadine	Fluoxetine	0.357	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#B32020	0.0884641821795982	1
Ramipril	Lithium cation	0.372	-1.085	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#B4D1E6	0.176928364359196	1
Fluconazole	Eplerenone	0.047	-1.085	Moderate	2 (1/1)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#B4D1E6	0.176928364359196	1
Phenytoin	Levonorgestrel	0.119	Inf	Major	2 (2/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Phenytoin.	#B32020	0.176928364359196	1
Ketoconazole	Aripiprazole	0.062	Inf	Moderate	1 (1/0)	The serum concentration of Aripiprazole can be increased when it is combined with Ketoconazole.	#B32020	0.0884641821795982	1
Warfarin	Clarithromycin	0.179	-1.085	Major	4 (2/2)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B4D1E6	0.353856728718393	1
Medroxyprogesterone acetate	Acenocoumarol	0.076	Inf	None	2 (2/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.176928364359196	1
Sucralfate	Levofloxacin	0.796	-1.446	Moderate	7 (3/4)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B2D0E5	0.619249275257188	1
Triazolam	Clarithromycin	0.197	-1.085	Moderate	2 (1/1)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#B4D1E6	0.176928364359196	1
Salmeterol	Nadolol	0.095	Inf	Major	2 (2/0)		#B32020	0.176928364359196	1
Cyclosporine	Metoclopramide	0.149	-2.893	Moderate	11 (3/8)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#A9C9E1	0.97310600397558	1
Amiodarone	Levofloxacin	0.082	-1.085	Major	2 (1/1)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	0.176928364359196	1
Ibuprofen	Oxprenolol	0.507	-1.085	None	2 (1/1)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#B4D1E6	0.176928364359196	1
Omeprazole	Chlordiazepoxide	0.1	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Erythromycin	Colchicine	0.333	Inf	Major	1 (1/0)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#B32020	0.0884641821795982	1
Ketoconazole	Budesonide	0.461	-1.446	Major	14 (6/8)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#B2D0E5	1.23849855051438	1
Theophylline	Propranolol	0.125	Inf	Major	1 (1/0)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#B32020	0.0884641821795982	1
Erythromycin	Tacrolimus	0.431	-1.085	Major	6 (3/3)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#B4D1E6	0.530785093077589	1
Ethinylestradiol	Benzylpenicillin	0.111	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Trospium	Cyclobenzaprine	0.25	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Warfarin	Ethinylestradiol	0.34	Inf	Moderate	2 (2/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Warfarin.	#B32020	0.176928364359196	1
Tacrolimus	Rifampicin	0.077	Inf	Major	1 (1/0)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#B32020	0.0884641821795982	1
Triamcinolone	Phenobarbital	0.111	Inf	Moderate	1 (1/0)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#B32020	0.0884641821795982	1
Bisoprolol	Rifampicin	0.059	-4.339	Moderate	5 (1/4)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#A0C3DD	0.442320910897991	1
Simvastatin	Colchicine	0.302	-24.949	Major	24 (1/23)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#1E61A5	2.12314037231036	1
Theophylline	Norfloxacin	0.087	Inf	Moderate	2 (2/0)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#B32020	0.176928364359196	1
Tizanidine	Captopril	0.288	-1.085	Major	2 (1/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#B4D1E6	0.176928364359196	1
Carbamazepine	Josamycin	0.031	Inf	None	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B32020	0.0884641821795982	1
Fluvoxamine	Almotriptan	0.051	-2.17	Major	3 (1/2)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#AECDE3	0.265392546538795	1
Warfarin	Itraconazole	0.059	Inf	Moderate	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#B32020	0.0884641821795982	1
Famotidine	Itraconazole	0.296	-3.254	Moderate	4 (1/3)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#A6C7E0	0.353856728718393	1
Ketoconazole	Atorvastatin	0.053	-3.254	Major	4 (1/3)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#A6C7E0	0.353856728718393	1
Doxycycline	Acenocoumarol	0.25	-2.712	None	7 (2/5)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#A9C9E1	0.619249275257188	1
Phenytoin	Ethinylestradiol	0.119	Inf	Major	2 (2/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.176928364359196	1
Griseofulvin	Ethinylestradiol	0.111	Inf	Major	1 (1/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Griseofulvin.	#B32020	0.0884641821795982	1
Eplerenone	Clarithromycin	0.054	-3.254	Major	4 (1/3)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#A6C7E0	0.353856728718393	1
Theophylline	Ciprofloxacin	0.889	-2.17	Major	6 (2/4)		#AECDE3	0.530785093077589	1
Fluconazole	Lovastatin	0.083	-1.085	Major	2 (1/1)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#B4D1E6	0.176928364359196	1
Sucralfate	Itraconazole	0.583	-2.17	None	6 (2/4)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AECDE3	0.530785093077589	1
Ketoconazole	Rabeprazole	1	Inf	Moderate	1 (1/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#B32020	0.0884641821795982	1
Metformin	Glucosamine	0.1	-1.627	None	5 (2/3)		#B1CFE5	0.442320910897991	1
Amitriptyline	Rifampicin	0.225	1.844	Minor	3 (2/1)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#F7B7B7	0.265392546538795	1
Ethinylestradiol	Acenocoumarol	0.119	Inf	None	4 (4/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.353856728718393	1
Minocycline	Acenocoumarol	0.079	-1.085	None	2 (1/1)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.176928364359196	1
Lidocaine	Labetalol	0.667	Inf	Moderate	1 (1/0)	The serum concentration of Lidocaine can be increased when it is combined with Labetalol.	#B32020	0.0884641821795982	1
Esomeprazole	Itraconazole	0.133	-1.898	Moderate	11 (4/7)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#AFCEE4	0.97310600397558	1
Atorvastatin	Josamycin	0.697	-2.17	None	3 (1/2)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#AECDE3	0.265392546538795	1
Erythromycin	Carbamazepine	0.319	-1.085	Major	4 (2/2)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#B4D1E6	0.353856728718393	1
Itraconazole	Acenocoumarol	0.139	-2.712	None	7 (2/5)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#A9C9E1	0.619249275257188	1
Rifampicin	Etoricoxib	0.254	-3.254	None	4 (1/3)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#A6C7E0	0.353856728718393	1
Irbesartan	Drospirenone	0.081	Inf	Moderate	1 (1/0)	Irbesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0884641821795982	1
Amitriptyline	Ketoconazole	0.133	Inf	Moderate	2 (2/0)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#B32020	0.176928364359196	1
Itraconazole	Ciclesonide	0.208	-1.085	Moderate	2 (1/1)	The metabolism of Ciclesonide can be decreased when combined with Itraconazole.	#B4D1E6	0.176928364359196	1
Doxycycline	Ampicillin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#B32020	0.0884641821795982	1
Cyclosporine	Norfloxacin	0.055	1.844	Moderate	3 (2/1)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#F7B7B7	0.265392546538795	1
Metoprolol	Escitalopram	0.5	Inf	Minor	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#B32020	0.0884641821795982	1
Erythromycin	Methylergometrine	1	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Erythromycin.	#B32020	0.176928364359196	1
Propranolol	Epinephrine	0.187	-1.085	Major	4 (2/2)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B4D1E6	0.353856728718393	1
Trazodone	Ketoconazole	0.083	-1.085	Moderate	2 (1/1)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B4D1E6	0.176928364359196	1
Fluconazole	Nortriptyline	0.333	Inf	Moderate	1 (1/0)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B32020	0.0884641821795982	1
Ofloxacin	Iron	0.75	Inf	None	2 (2/0)		#B32020	0.176928364359196	1
Cyclosporine	Clarithromycin	0.154	-2.17	Major	6 (2/4)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#AECDE3	0.530785093077589	1
Esomeprazole	Ketoconazole	0.611	-2.17	Moderate	3 (1/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#AECDE3	0.265392546538795	1
Trospium	Loratadine	0.133	Inf	None	1 (1/0)		#B32020	0.0884641821795982	1
Hydrocortisone	Rifampicin	0.351	-3.254	Moderate	4 (1/3)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#A6C7E0	0.353856728718393	1
Clozapine	Ciprofloxacin	0.057	-7.593	Major	8 (1/7)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#8BB3D4	0.707713457436786	1
Thiethylperazine	Bromocriptine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.0884641821795982	1
Fluconazole	Warfarin	0.104	-1.085	Major	2 (1/1)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#B4D1E6	0.176928364359196	1
Propranolol	Rifampicin	0.147	-3.254	Moderate	4 (1/3)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#A6C7E0	0.353856728718393	1
Imipramine	Salbutamol	0.095	-3.254	Moderate	8 (2/6)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#A6C7E0	0.707713457436786	1
Cyclosporine	Itraconazole	0.154	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#B32020	0.0884641821795982	1
Fluconazole	Phenytoin	0.517	-1.085	Moderate	2 (1/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#B4D1E6	0.176928364359196	1
Epinephrine	Clomipramine	0.049	-2.17	Major	3 (1/2)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#AECDE3	0.265392546538795	1
Doxycycline	Rifampicin	0.938	-7.593	Moderate	8 (1/7)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#8BB3D4	0.707713457436786	1
Indomethacin	Lithium cation	0.066	-1.085	Major	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#B4D1E6	0.176928364359196	1
Simvastatin	Ketoconazole	0.217	-2.17	Major	3 (1/2)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#AECDE3	0.265392546538795	1
Moxifloxacin	Iron	0.806	Inf	Moderate	6 (6/0)		#B32020	0.530785093077589	1
Olmesartan	Drospirenone	0.111	Inf	Moderate	1 (1/0)	Olmesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0884641821795982	1
Simvastatin	Fusidic acid	0.117	-7.593	None	8 (1/7)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#8BB3D4	0.707713457436786	1
Doxycycline	Phenoxymethylpenicillin	0.781	2.766	Moderate	4 (3/1)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#F4B1B1	0.353856728718393	1
Erythromycin	Dihydroergotamine	0.303	-2.17	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#AECDE3	0.265392546538795	1
Sucralfate	Norfloxacin	0.544	-1.627	Moderate	5 (2/3)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#B1CFE5	0.442320910897991	1
Thiethylperazine	Levofloxacin	0.833	-1.085	None	6 (3/3)		#B4D1E6	0.530785093077589	1
Terbutaline	Nadolol	0.267	-1.085	Major	2 (1/1)		#B4D1E6	0.176928364359196	1
Tizanidine	Lisinopril	0.229	-4.339	Major	5 (1/4)	Tizanidine may increase the hypotensive activities of Lisinopril.	#A0C3DD	0.442320910897991	1
Fentanyl	Itraconazole	0.035	-1.085	Major	2 (1/1)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#B4D1E6	0.176928364359196	1
Indomethacin	Labetalol	0.333	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#B32020	0.0884641821795982	1
Itraconazole	Josamycin	0.5	Inf	None	1 (1/0)		#B32020	0.0884641821795982	1
Erythromycin	Ergotamine	0.059	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#B32020	0.0884641821795982	1
Gentamicin	Cefazolin	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	0.139913181251601
Amiodarone	Flecainide	0.18	-Inf	Major	9 (0/9)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#1E61A5	0.796177639616384	1.91450872474638e-10
Ziprasidone	Galantamine	0.071	-Inf	Moderate	1 (0/1)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.0884641821795982	1
Verapamil	Lithium cation	0.351	-Inf	Moderate	17 (0/17)	Verapamil may increase the neurotoxic activities of Lithium.	#1E61A5	1.50389109705317	1.08924841693805e-10
Ranolazine	Amiodarone	0.067	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#1E61A5	0.0884641821795982	1
Ranolazine	Diltiazem	0.167	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#1E61A5	0.0884641821795982	1
Cyclosporine	Sirolimus	0.438	-Inf	Moderate	4 (0/4)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#1E61A5	0.353856728718393	0.00236359092719648
Warfarin	Propafenone	0.466	-Inf	Moderate	3 (0/3)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#1E61A5	0.265392546538795	0.0224405545116876
Sotalol	Clonidine	0.154	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#1E61A5	0.0884641821795982	1
Prazosin	Carvedilol	0.345	-Inf	Moderate	1 (0/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#1E61A5	0.0884641821795982	1
Disopyramide	Bisoprolol	0.708	-Inf	Major	2 (0/2)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#1E61A5	0.176928364359196	0.2998259312556
Fludrocortisone	Primidone	0.059	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Primidone.	#1E61A5	0.0884641821795982	1
Trospium	Haloperidol	0.061	-Inf	Moderate	2 (0/2)		#1E61A5	0.176928364359196	1
Erythromycin	Lincomycin	0.806	-Inf	Moderate	6 (0/6)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#1E61A5	0.530785093077589	0.0209935361226822
Metoprolol	Hydralazine	1	-Inf	Minor	1 (0/1)	Hydralazine may increase the hypotensive activities of Metoprolol.	#1E61A5	0.0884641821795982	1
Dapsone	Rifampicin	0.091	-Inf	Moderate	1 (0/1)	The metabolism of Dapsone can be increased when combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Clozapine	Flurazepam	0.167	-Inf	Major	3 (0/3)	The risk or severity of adverse effects can be increased when Flurazepam is combined with Clozapine.	#1E61A5	0.265392546538795	1
Ticlopidine	Carbamazepine	0.032	-Inf	Moderate	1 (0/1)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#1E61A5	0.0884641821795982	1
Cyclosporine	Danazol	0.059	-Inf	Moderate	1 (0/1)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#1E61A5	0.0884641821795982	1
Rivastigmine	Quetiapine	0.545	-Inf	Moderate	2 (0/2)		#1E61A5	0.176928364359196	1
Rivastigmine	Methotrimeprazine	0.069	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Rifampicin	Glipizide	0.143	-Inf	Moderate	1 (0/1)	The serum concentration of Glipizide can be decreased when it is combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Disopyramide	Propranolol	0.857	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.0884641821795982	1
Naltrexone	Buprenorphine	0.571	-Inf	Major	4 (0/4)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.353856728718393	0.151487606879455
Disopyramide	Atenolol	0.571	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Atenolol.	#1E61A5	0.0884641821795982	1
Methadone	Rifampicin	0.571	-Inf	Major	2 (0/2)	The serum concentration of Methadone can be decreased when it is combined with Rifampicin.	#1E61A5	0.176928364359196	1
Eletriptan	Dihydroergotamine	0.26	-Inf	Major	2 (0/2)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#1E61A5	0.176928364359196	1
Labetalol	Glyburide	0.25	-Inf	Moderate	1 (0/1)	Labetalol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.0884641821795982	1
Galantamine	Risperidone	0.125	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Prazosin	Propranolol	0.394	-Inf	Moderate	1 (0/1)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.0884641821795982	1
Phenytoin	Quazepam	0.031	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Quazepam.	#1E61A5	0.0884641821795982	1
Acitretin	Methotrexate	0.144	-Inf	Major	4 (0/4)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#1E61A5	0.353856728718393	1
Triazolam	Josamycin	0.038	-Inf	None	1 (0/1)	The serum concentration of Triazolam can be increased when it is combined with Josamycin.	#1E61A5	0.0884641821795982	1
Phenytoin	Felodipine	0.038	-Inf	Major	1 (0/1)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#1E61A5	0.0884641821795982	1
Verapamil	Carvedilol	0.634	-Inf	Major	4 (0/4)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#1E61A5	0.353856728718393	1
Methylergometrine	Nitroglycerin	1	-Inf	Moderate	1 (0/1)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#1E61A5	0.0884641821795982	1
Prazosin	Bisoprolol	1	-Inf	Moderate	1 (0/1)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.0884641821795982	1
Felodipine	Phenobarbital	0.029	-Inf	Moderate	1 (0/1)	The metabolism of Felodipine can be increased when combined with Phenobarbital.	#1E61A5	0.0884641821795982	1
Propranolol	Propafenone	0.055	-Inf	Moderate	3 (0/3)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#1E61A5	0.265392546538795	1
Verapamil	Eplerenone	0.245	-Inf	Moderate	2 (0/2)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#1E61A5	0.176928364359196	1
Furosemide	Gentamicin	0.283	-Inf	Major	2 (0/2)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#1E61A5	0.176928364359196	1
Carvedilol	Insulin glulisine	0.455	-Inf	Moderate	4 (0/4)		#1E61A5	0.353856728718393	1
Propranolol	Clonidine	0.75	-Inf	Major	2 (0/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#1E61A5	0.176928364359196	1
Cyclosporine	Phenytoin	0.288	-Inf	Moderate	3 (0/3)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#1E61A5	0.265392546538795	1
Clonidine	Carvedilol	0.333	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#1E61A5	0.0884641821795982	1
Cyclophosphamide	Acenocoumarol	0.125	-Inf	None	1 (0/1)		#1E61A5	0.0884641821795982	1
Trazodone	Donepezil	0.071	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Verapamil	Nadolol	0.483	-Inf	Major	2 (0/2)	Verapamil may increase the hypotensive activities of Nadolol.	#1E61A5	0.176928364359196	1
Spironolactone	Quinapril	0.364	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#1E61A5	0.0884641821795982	1
Phenytoin	Methadone	0.667	-Inf	Major	1 (0/1)	The serum concentration of Methadone can be decreased when it is combined with Phenytoin.	#1E61A5	0.0884641821795982	1
Selegiline	Escitalopram	0.167	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#1E61A5	0.0884641821795982	1
Atenolol	Verapamil	0.245	-Inf	Major	6 (0/6)	Verapamil may increase the hypotensive activities of Atenolol.	#1E61A5	0.530785093077589	1
Rifabutin	Acenocoumarol	0.077	-Inf	None	1 (0/1)	The metabolism of Acenocoumarol can be increased when combined with Rifabutin.	#1E61A5	0.0884641821795982	1
Dextropropoxyphene	Warfarin	0.5	-Inf	None	1 (0/1)		#1E61A5	0.0884641821795982	1
Torasemide	Gentamicin	0.091	-Inf	Major	1 (0/1)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#1E61A5	0.0884641821795982	1
Paroxetine	Moclobemide	0.225	-Inf	None	2 (0/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#1E61A5	0.176928364359196	1
Trospium	Biperiden	0.057	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#1E61A5	0.0884641821795982	1
Rosuvastatin	Colchicine	0.161	-Inf	Moderate	5 (0/5)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#1E61A5	0.442320910897991	1
Ziprasidone	Pimozide	0.093	-Inf	Major	1 (0/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#1E61A5	0.0884641821795982	1
Warfarin	Fenofibrate	0.309	-Inf	Major	4 (0/4)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#1E61A5	0.353856728718393	1
Indomethacin	Carvedilol	0.183	-Inf	Moderate	7 (0/7)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#1E61A5	0.619249275257188	1
Metoprolol	Phenobarbital	0.029	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#1E61A5	0.0884641821795982	1
Repaglinide	Carvedilol	0.066	-Inf	Moderate	2 (0/2)		#1E61A5	0.176928364359196	1
Valsartan	Lithium cation	0.183	-Inf	Moderate	6 (0/6)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#1E61A5	0.530785093077589	1
Spironolactone	Tolevamer	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Chlorthalidone	Lithium cation	0.145	-Inf	Major	2 (0/2)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#1E61A5	0.176928364359196	1
Griseofulvin	Phenobarbital	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Griseofulvin can be decreased when it is combined with Phenobarbital.	#1E61A5	0.0884641821795982	1
Testosterone	Warfarin	0.474	-Inf	Major	2 (0/2)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.176928364359196	1
Olanzapine	Donepezil	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Tobramycin	Cefuroxime	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Sotalol	Gliclazide	0.036	-Inf	None	1 (0/1)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.0884641821795982	1
Carbamazepine	Felodipine	0.03	-Inf	Moderate	1 (0/1)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#1E61A5	0.0884641821795982	1
Primidone	Dexamethasone	0.056	-Inf	Moderate	1 (0/1)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#1E61A5	0.0884641821795982	1
Fludrocortisone	Phenobarbital	0.545	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#1E61A5	0.0884641821795982	1
Betamethasone	Phenobarbital	0.053	-Inf	Moderate	2 (0/2)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#1E61A5	0.176928364359196	1
Clonidine	Clomipramine	1	-Inf	Major	1 (0/1)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.0884641821795982	1
Warfarin	Fluvastatin	0.158	-Inf	Minor	1 (0/1)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#1E61A5	0.0884641821795982	1
Clozapine	Bromazepam	0.178	-Inf	None	3 (0/3)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#1E61A5	0.265392546538795	1
Cyclosporine	Lovastatin	0.633	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#1E61A5	0.0884641821795982	1
Pravastatin	Colchicine	0.292	-Inf	Major	4 (0/4)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#1E61A5	0.353856728718393	1
Repaglinide	Nadolol	0.179	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Phenytoin	Sucralfate	0.282	-Inf	Moderate	2 (0/2)		#1E61A5	0.176928364359196	1
Spironolactone	Eprosartan	1	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#1E61A5	0.0884641821795982	1
Hydroxyzine	Donepezil	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Lovastatin	Clarithromycin	0.055	-Inf	Major	6 (0/6)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#1E61A5	0.530785093077589	1
Ampicillin	Minocycline	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Minocycline.	#1E61A5	0.0884641821795982	1
Clozapine	Midazolam	0.618	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#1E61A5	0.0884641821795982	1
Diltiazem	Carbamazepine	0.182	-Inf	Major	2 (0/2)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#1E61A5	0.176928364359196	1
Cyclosporine	Amiodarone	0.018	-Inf	Moderate	1 (0/1)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#1E61A5	0.0884641821795982	1
Haloperidol	Glycopyrronium	0.429	-Inf	Moderate	1 (0/1)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#1E61A5	0.0884641821795982	1
Imipramine	Ketoconazole	0.062	-Inf	Moderate	1 (0/1)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#1E61A5	0.0884641821795982	1
Warfarin	Pentoxifylline	0.406	-Inf	Moderate	1 (0/1)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0884641821795982	1
Pravastatin	Bezafibrate	0.769	-Inf	None	1 (0/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#1E61A5	0.0884641821795982	1
Acetylsalicylic acid	Ginkgo biloba	0.384	-Inf	Moderate	4 (0/4)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#1E61A5	0.353856728718393	1
Phenytoin	Flurazepam	0.556	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#1E61A5	0.0884641821795982	1
Cyclosporine	Sulfasalazine	0.286	-Inf	Major	1 (0/1)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.0884641821795982	1
Isoniazid	Acenocoumarol	0.213	-Inf	None	3 (0/3)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#1E61A5	0.265392546538795	1
Repaglinide	Josamycin	0.034	-Inf	None	1 (0/1)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#1E61A5	0.0884641821795982	1
Cyclosporine	Bupropion	0.034	-Inf	Moderate	2 (0/2)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.176928364359196	1
Propranolol	Repaglinide	0.173	-Inf	Moderate	2 (0/2)		#1E61A5	0.176928364359196	1
Disulfiram	Acenocoumarol	0.173	-Inf	None	5 (0/5)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#1E61A5	0.442320910897991	1
Rifabutin	Itraconazole	0.5	-Inf	None	1 (0/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rifabutin.	#1E61A5	0.0884641821795982	1
Verapamil	Midazolam	0.136	-Inf	Moderate	1 (0/1)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#1E61A5	0.0884641821795982	1
Trospium	Hydroxyzine	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Warfarin	Rifampicin	0.667	-Inf	Major	1 (0/1)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Pimozide	Itraconazole	0.025	-Inf	Major	2 (0/2)	The serum concentration of Pimozide can be increased when it is combined with Itraconazole.	#1E61A5	0.176928364359196	1
Cyclosporine	Verapamil	0.419	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#1E61A5	0.0884641821795982	1
Allopurinol	Warfarin	0.67	-Inf	Moderate	2 (0/2)	Allopurinol may increase the anticoagulant activities of Warfarin.	#1E61A5	0.176928364359196	1
Doxycycline	Primidone	0.026	-Inf	Moderate	1 (0/1)	The serum concentration of Doxycycline can be decreased when it is combined with Primidone.	#1E61A5	0.0884641821795982	1
Dextropropoxyphene	Acenocoumarol	0.667	-Inf	None	1 (0/1)		#1E61A5	0.0884641821795982	1
Cyclosporine	Glyburide	0.417	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#1E61A5	0.0884641821795982	1
Midazolam	Josamycin	0.038	-Inf	None	1 (0/1)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#1E61A5	0.0884641821795982	1
Colestipol	Hydrocortisone	0.2	-Inf	Moderate	1 (0/1)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.0884641821795982	1
Itraconazole	Quazepam	1	-Inf	None	1 (0/1)	The metabolism of Quazepam can be decreased when combined with Itraconazole.	#1E61A5	0.0884641821795982	1
Verapamil	Phenobarbital	0.059	-Inf	Moderate	1 (0/1)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#1E61A5	0.0884641821795982	1
Fluvoxamine	Oxycodone	0.167	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#1E61A5	0.0884641821795982	1
Warfarin	Hydrocortisone	0.08	-Inf	Moderate	2 (0/2)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.176928364359196	1
Disulfiram	Isoniazid	0.221	-Inf	Moderate	4 (0/4)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#1E61A5	0.353856728718393	1
Warfarin	Isoniazid	0.667	-Inf	Moderate	1 (0/1)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#1E61A5	0.0884641821795982	1
Primidone	Metronidazole	0.136	-Inf	Moderate	1 (0/1)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#1E61A5	0.0884641821795982	1
Repaglinide	Rifampicin	0.071	-Inf	Moderate	1 (0/1)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Theophylline	Lithium cation	0.045	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#1E61A5	0.0884641821795982	1
Dihydroergotamine	Nitroglycerin	1	-Inf	Moderate	2 (0/2)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#1E61A5	0.176928364359196	1
Cyclosporine	Phenobarbital	0.455	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#1E61A5	0.0884641821795982	1
Allopurinol	Azathioprine	0.188	-Inf	Major	4 (0/4)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#1E61A5	0.353856728718393	1
Azithromycin	Lovastatin	0.173	-Inf	Moderate	5 (0/5)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#1E61A5	0.442320910897991	1
Fluconazole	Everolimus	0.037	-Inf	Major	1 (0/1)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#1E61A5	0.0884641821795982	1
Rifampicin	Fluvastatin	0.029	-Inf	Moderate	1 (0/1)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Warfarin	Gemfibrozil	0.25	-Inf	Major	2 (0/2)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#1E61A5	0.176928364359196	1
Meloxicam	Lithium cation	0.047	-Inf	Major	2 (0/2)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#1E61A5	0.176928364359196	1
Cilostazol	Itraconazole	0.036	-Inf	Major	1 (0/1)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.0884641821795982	1
Ergotamine	Carvedilol	0.222	-Inf	Moderate	1 (0/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#1E61A5	0.0884641821795982	1
Erythromycin	Pimozide	0.043	-Inf	Major	1 (0/1)	The serum concentration of Pimozide can be increased when it is combined with Erythromycin.	#1E61A5	0.0884641821795982	1
Ergotamine	Ketoconazole	0.364	-Inf	Major	1 (0/1)	The serum concentration of Ergotamine can be increased when it is combined with Ketoconazole.	#1E61A5	0.0884641821795982	1
Pregabalin	Rosiglitazone	0.5	-Inf	Moderate	1 (0/1)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#1E61A5	0.0884641821795982	1
Fluvoxamine	Phenytoin	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#1E61A5	0.0884641821795982	1
Ergotamine	Nitroglycerin	0.682	-Inf	Moderate	2 (0/2)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#1E61A5	0.176928364359196	1
Citalopram	Rasagiline	0.677	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#1E61A5	0.0884641821795982	1
Rifampicin	Itraconazole	0.556	-Inf	Major	4 (0/4)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#1E61A5	0.353856728718393	1
Carbamazepine	Warfarin	0.077	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#1E61A5	0.0884641821795982	1
Phenytoin	Triamcinolone	0.085	-Inf	Moderate	2 (0/2)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#1E61A5	0.176928364359196	1
Fluvoxamine	Ergotamine	0.143	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#1E61A5	0.0884641821795982	1
Digoxin	Rabeprazole	0.056	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Fluvastatin	Colchicine	0.053	-Inf	Major	1 (0/1)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#1E61A5	0.0884641821795982	1
Cyclosporine	Indomethacin	0.532	-Inf	Moderate	2 (0/2)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.176928364359196	1
Cyclosporine	Rifampicin	0.375	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Phenytoin	Rifampicin	0.304	-Inf	Major	1 (0/1)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Rifampicin	Clomipramine	0.037	-Inf	Minor	2 (0/2)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#1E61A5	0.176928364359196	1
Cyclosporine	Rosuvastatin	0.571	-Inf	Major	1 (0/1)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#1E61A5	0.0884641821795982	1
Captopril	Lithium cation	0.083	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#1E61A5	0.0884641821795982	1
Acenocoumarol	Cholestyramine	0.44	-Inf	None	1 (0/1)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.0884641821795982	1
Verapamil	Colchicine	0.1	-Inf	Major	1 (0/1)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#1E61A5	0.0884641821795982	1
Phenytoin	Isoniazid	0.304	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#1E61A5	0.0884641821795982	1
Fluvoxamine	Tizanidine	0.041	-Inf	Major	2 (0/2)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#1E61A5	0.176928364359196	1
Celecoxib	Warfarin	0.048	-Inf	Moderate	1 (0/1)	Celecoxib may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0884641821795982	1
Ceftriaxone	Acenocoumarol	0.5	-Inf	None	1 (0/1)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.0884641821795982	1
Phenytoin	Doxycycline	0.044	-Inf	Moderate	2 (0/2)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#1E61A5	0.176928364359196	1
Simvastatin	Rifampicin	0.302	-Inf	Major	4 (0/4)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#1E61A5	0.353856728718393	1
Isoniazid	Ketoconazole	0.2	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Isoniazid.	#1E61A5	0.0884641821795982	1
Digoxin	Clarithromycin	0.618	-Inf	Major	2 (0/2)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#1E61A5	0.176928364359196	1
Indomethacin	Warfarin	0.071	-Inf	Major	1 (0/1)	Indomethacin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0884641821795982	1
Warfarin	Disulfiram	0.071	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#1E61A5	0.0884641821795982	1
Moxifloxacin	Amiodarone	0.111	-Inf	Major	1 (0/1)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.0884641821795982	1
Ciprofloxacin	Rasagiline	0.2	-Inf	Major	1 (0/1)		#1E61A5	0.0884641821795982	1
Prednisone	Primidone	0.038	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#1E61A5	0.0884641821795982	1
Atorvastatin	Fusidic acid	0.117	-Inf	None	2 (0/2)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#1E61A5	0.176928364359196	1
Imipramine	Terbutaline	1	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#1E61A5	0.0884641821795982	1
Rifampicin	Bupropion	0.077	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Doxycycline	Acitretin	0.25	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#1E61A5	0.0884641821795982	1
Doxycycline	Warfarin	0.05	-Inf	Moderate	1 (0/1)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#1E61A5	0.0884641821795982	1
Carbamazepine	Isoniazid	0.182	-Inf	Moderate	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#1E61A5	0.0884641821795982	1
Oxytetracycline	Amoxicillin	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Moxifloxacin	Josamycin	0.5	-Inf	None	1 (0/1)		#1E61A5	0.0884641821795982	1
Celecoxib	Rifampicin	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#1E61A5	0.0884641821795982	1
Moxifloxacin	Sucralfate	0.045	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
Phenoxymethylpenicillin	Tetracycline	1	-Inf	None	1 (0/1)		#1E61A5	0.0884641821795982	1
Lansoprazole	Ketoconazole	0.273	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#1E61A5	0.0884641821795982	1
Warfarin	Cloxacillin	0.034	-Inf	Moderate	1 (0/1)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#1E61A5	0.0884641821795982	1
Triamcinolone	Acenocoumarol	0.048	-Inf	None	1 (0/1)		#1E61A5	0.0884641821795982	1
Phenoxymethylpenicillin	Minocycline	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Minocycline.	#1E61A5	0.0884641821795982	1
Tetracycline	Cloxacillin	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.0884641821795982	1
